Substance list · United Kingdom
GB mandatory classification and labelling list (GB MCL list, GB CLP Article 38A), file of 19 May 2026 (page 4)
Labelling: mandatory hazard classification, labelling, specific concentration limits, M factors and ATEs.
- When it applies
- Every substance on the list and every mixture containing it, placed on the GB market
- Entries
- 4429
- Version date
- 2026-05-19
- Guide
- United Kingdom
Entries 1501 to 2000 of 4429
500 rows
| Substance | English name | CAS | EC | Type | Category | Threshold | Conditions |
|---|---|---|---|---|---|---|---|
| quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one | quinomethionate; chinomethionat (ISO); 6-methyl-1,3-dithiolo(4,5-b)quinoxalin-2-one | 2439-01-2 | 219-455-3 | substance | Repr. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H361f ***; H332; H312; H302; H373 **; H319; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361f ***; H332; H312; H302; H373 **; H319; H317; H410 | |
| triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone | triadimefon (ISO); 1-(4-chlorophenoxy)-3,3-dimethyl-1-(1,2,4-triazol-1-yl)butanone | 43121-43-3 | 256-103-8 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| diphacinone (ISO); 2-diphenylacetylindan-1,3-dione | diphacinone (ISO); 2-diphenylacetylindan-1,3-dione | 82-66-6 | 201-434-5 | substance | Acute Tox. 2 *; STOT RE 1 | Hazard statement codes: H300; H372 **. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H300; H372 ** | |
| 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino- 3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one | 5(or 6)-tert-butyl-2'-chloro-6'-ethylamino- 3',7'-dimethylspiro(isobenzofuran-1(1H),9'-xanthene)-3-one | 400-680-2 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H410 | ||
| (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride | (N-benzyl-N-ethyl)amino-3-hydroxyacetophenone hydrochloride | 55845-90-4 | 401-840-4 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | |
| 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one | 2-methyl-1-(4-methylthiophenyl)-2-morpholinopropan-1-one | 71868-10-5 | 400-600-6 | substance | Repr. 1B; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H360FD; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H360FD; H302; H411’ | |
| acetophenone | acetophenone | 98-86-2 | 202-708-7 | substance | Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H302; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319 | |
| 2,4-di-tert-butylcyclohexanone | 2,4-di-tert-butylcyclohexanone | 13019-04-0 | 405-340-7 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | |
| 2,4,6-trimethylbenzophenone | 2,4,6-trimethylbenzophenone | 954-16-5 | 403-150-9 | substance | Acute Tox. 4 *; Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H410 | |
| oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one | oxadiazon (ISO); 3-[2,4-dichloro-5-(1-methylethoxy)phenyl]-5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2(3H)-one | 19666-30-9 | 243-215-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| reaction mass of cis- and trans-cyclohexadec-8-en-1-one | reaction mass of cis- and trans-cyclohexadec-8-en-1-one | 3100-36-5 | 401-700-2 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone | 2-benzyl-2-dimethylamino-4'-morpholinobutyrophenone | 119313-12-1 | 404-360-3 | substance | Repr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360D; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360D; H410’ | |
| 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one | 2'-anilino-3'-methyl-6'-dipentylaminospiro(isobenzofuran-1(1H),9'-xanthen)-3-one | 406-480-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| 4-(trans-4-propylcyclohexyl)acetophenone | 4-(trans-4-propylcyclohexyl)acetophenone | 78531-61-0 | 406-700-6 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione | 6-anilino-1-benzoyl-4-(4-tert-pentylphenoxy)naphto[1,2,3-de]quinoline-2,7-(3H)-dione | 72453-58-8 | 412-480-2 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 4-pentylcyclohexanone | 4-pentylcyclohexanone | 61203-83-6 | 406-670-4 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone | 4-(N,N-dibutylamino)-2-hydroxy-2'-carboxybenzophenone | 54574-82-2 | 410-410-5 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one | flurtamone (ISO); (RS)-5-methylamino-2-phenyl-4-(α,α,α-trifluoro-m-tolyl)furan-3(2H)-one | 96525-23-4 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| isoxaflutole (ISO); 5-cyclopropyl-1,2- oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone | isoxaflutole (ISO); 5-cyclopropyl-1,2- oxazol-4-yl α,α,α-trifluoro-2-mesyl-p-tolyl ketone | 141112-29-0 | substance | Repr. 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | M = 100 | Hazard statement codes: H361d ***; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361d ***; H410 | |
| 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone | 1-(2,3-dihydro-1,3,3,6-tetramethyl-1-(1-methylethyl)-1H-inden-5-yl)ethanone | 92836-10-7 | 411-180-9 | substance | Acute Tox. 4 *; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H302; H373 **; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H302; H373 **; H411 | |
| 4-chloro-3',4'-dimethoxybenzophenone | 4-chloro-3',4'-dimethoxybenzophenone | 116412-83-0 | 404-610-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 4-propylcyclohexanone | 4-propylcyclohexanone | 40649-36-3 | 406-810-4 | substance | Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H315; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H412 | |
| 4'-fluoro-2,2-dimethoxyacetophenone | 4'-fluoro-2,2-dimethoxyacetophenone | 21983-80-2 | 407-500-1 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride | 2,4-difluoro-α-(1H-1,2,4-triazol-1-yl)acetophenone hydrochloride | 86386-75-6 | 412-390-3 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H317 | |
| reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthalene-2-yl)-1,3-ioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane | reaction mass of: trans-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethylnaphthalene-2-yl)-1,3-ioxolane; cis-2,4-dimethyl-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-naphthalene-2-yl)-1,3-dioxolane | 412-950-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone | (3-chlorophenyl)-(4-methoxy-3-nitrophenyl)methanone | 66938-41-8 | 423-290-4 | substance | Muta. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H341; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H341; H410 | |
| tetrahydrothiopyran-3-carboxaldehyde | tetrahydrothiopyran-3-carboxaldehyde | 61571-06-0 | 407-330-8 | substance | Repr. 1B; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H360D ***; H318; H412. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H360D ***; H318; H412 | |
| (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal | (E)-3-(2-chlorophenyl)-2-(4-fluorophenyl)propenal | 112704-51-5 | 410-980-5 | substance | Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H317 | |
| pregn-5-ene-3,20-dione bis(ethylene ketal) | pregn-5-ene-3,20-dione bis(ethylene ketal) | 7093-55-2 | 407-450-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 1-(4-morpholinophenyl)butan-1-one | 1-(4-morpholinophenyl)butan-1-one | 413-790-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone | (E)-5[(4-chlorophenyl)methylene]-2,2-dimethylcyclopentanone | 164058-20-2 | 410-440-9 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1Hbenz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1Hbenz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1Hbenz(g)inden-5-yl)ethanone | reaction mass of: 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1H-benz(g)inden-4-yl)ethanone; 1-(2,3,5,6,7,8-hexahydro-1,1-dimethyl-1Hbenz(f)inden-4-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-1,1-dimethyl-1Hbenz(g)inden-5-yl)ethanone; 1-(2,3,6,7,8,9-hexahydro-3,3-dimethyl-1Hbenz(g)inden-5-yl)ethanone | 96792-67-5 | 414-870-8 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al | 2,7,11-trimethyl-13-(2,6,6-trimethylcyclohex-1-en-1-yl)tridecahexaen-2,4,6,8,10,12-al | 1638-05-7 | 415-770-7 | substance | STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H373 **; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H373 **; H317; H412 | |
| spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] | spiro[1,3-dioxolane-2,5'-(4',4',8',8'-tetramethyl-hexahydro-3',9'-methanonaphthalene)] | 154171-76-3 | 415-460-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one | butroxydim (ISO); 5-(3-butyryl-2,4,6-trimethylphenyl)-2-[1-(ethoxyimino)propyl]-3-hydroxycyclohex-2-en-1-one | 138164-12-2 | 414-790-3 | substance | Repr. 2; Acute Tox. 4 *; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H361fd; H302; H315; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361fd; H302; H315; H410 | |
| 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one | 17-spiro(5,5-dimethyl-1,3-dioxan-2-yl)androsta-1,4-diene-3-one | 13258-43-0 | 421-050-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 3-acetyl-1-phenyl-pyrrolidine-2,4-dione | 3-acetyl-1-phenyl-pyrrolidine-2,4-dione | 719-86-8 | 421-600-2 | substance | STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H373 **; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373 **; H411 | |
| 4,4'-bis(dimethylamino)benzophenone; Michler's ketone | 4,4'-bis(dimethylamino)benzophenone; Michler's ketone | 90-94-8 | 202-027-5 | substance | Carc. 1B; Muta. 2; Eye Dam. 1 | Hazard statement codes: H350; H341; H318. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H350; H341; H318 | |
| reaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R*, 3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene | reaction mass of: (1R*, 2S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-1,2,8,8-tetramethylnaphthalene; (2R*, 3S*)-2-acetyl-1,2,3,4,5,6,7,8-octahydro-2,3,8,8-tetramethylnaphthalene | 425-570-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| 1-benzyl-5-ethoxyimidazolidine-2,4-dione | 1-benzyl-5-ethoxyimidazolidine-2,4-dione | 65855-02-9 | 417-340-4 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione | 1-((2-quinolinyl-carbonyl)oxy)-2,5-pyrrolidinedione | 136465-99-1 | 418-630-3 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | |
| (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone | (3S,4S)-3-hexyl-4-[(R)-2-hydroxytridecyl]-2-oxetanone | 104872-06-2 | 418-650-2 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 1-octylazepin-2-one | 1-octylazepin-2-one | 59227-88-2 | 420-040-6 | substance | Skin Corr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H314; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H411 | |
| 2-n-butyl-benzo[d]isothiazol-3-one | 2-n-butyl-benzo[d]isothiazol-3-one | 4299-07-4 | 420-590-7 | substance | Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H410 | |
| (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one | (3β, 5α, 6β)-3-(acetyloxy)-5-bromo-6-hydroxy-androstan-17-one | 4229-69-0 | 419-790-7 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane | reaction mass of: butan-2-one oxime; syn-O,O'-di(butan-2-one oxime)diethoxysilane | 406-930-7 | substance | STOT RE 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H372 **; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H372 **; H317; H412 | ||
| 2-chloro-5-sec-hexadecylhydroquinone | 2-chloro-5-sec-hexadecylhydroquinone | 137193-60-3 | 407-750-1 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H319; H315; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H317; H412 | |
| 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione | 1-(4-methoxy-5-benzofuranyl)-3-phenyl-1,3-propanedione | 484-33-3 | 414-540-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one | (1R,4S)-2-azabicyclo[2.2.1]hept-5-en-3-one | 79200-56-9 | 418-530-1 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H317 | |
| 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one | 1-(3,3-dimethylcyclohexyl)pent-4-en-1-one | 56973-87-6 | 422-330-8 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 6-ethyl-5-fluoro-4(3H)-pyrimidone | 6-ethyl-5-fluoro-4(3H)-pyrimidone | 137234-87-8 | 422-460-5 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| 2,4,4,7-tetramethyl-6-octen-3-one | 2,4,4,7-tetramethyl-6-octen-3-one | 74338-72-0 | 422-520-0 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | |
| reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone | reaction mass of: 1,4-diamino-2-chloro-3-phenoxyanthraquinone; 1,4-diamino-2,3-bis-phenoxyanthraquinone | 12223-77-7 | 423-220-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 1-[3-[(dimethylamino)methyl] -4-hydroxyphenyl]ethanone | 1-[3-[(dimethylamino)methyl] -4-hydroxyphenyl]ethanone | 73096-98-7 | 430-920-1 | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H318; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318; H412 | |
| 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one | 6-chloro-5-(2-chloroethyl)-1,3-dihydroindol-2-one | 118289-55-7 | 421-320-0 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one | reaction mass of: (E)-oxacyclohexadec-12-en-2-one; (E)-oxacyclohexadec-13-en-2-one; a) (Z)-oxacyclohexadec-(12)-en-2-one and b) (Z)-oxacyclohexadec-(13)-en-2-one | 422-320-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one | 5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one | 95885-13-5 | 414-470-3 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1’(3’H)-isobenzofuran]-3’-one | N-[ethyl(3-methylbutyl)amino]-3-methyl-1-phenyl-spiro[[1]benzo-pyrano[2,3-c]pyrazole-4(1H), 1’(3’H)-isobenzofuran]-3’-one | 417-460-7 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| (R,S)-2-azabicyclo[2.2.1] hept-5-en-3-one | (R,S)-2-azabicyclo[2.2.1] hept-5-en-3-one | 49805-30-3 | 421-830-3 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| 3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4 H-1-benzopyran-4-one | 3-(6-O-(6-desoxy-α-l-mannopyranosyl-O-(α-d-glucopyranosyl)-(β-d-glucopyranosyl)oxy)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4 H-1-benzopyran-4-one | 130603-71-3 | 424-170-4 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| 2,2’’-dihydroxy-4,4’’-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone | 2,2’’-dihydroxy-4,4’’-(2-hydroxy-propane-1,3-diyldioxy)dibenzophenone | 23911-85-5 | 424-210-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione | 1-benzyl-5-(hexadecyloxy)-2,4-imidazolidinedione | 158574-65-3 | 431-220-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 5-methoxy-4’-(trifluoromethyl)valerophenone | 5-methoxy-4’-(trifluoromethyl)valerophenone | 61718-80-7 | 425-000-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one | 2-butyryl-3-hydroxy-5-thiocyclohexan-3-yl-cyclohex-2-en-1-one | 94723-86-1 | 425-150-8 | substance | Repr. 1B; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H360F***; H302; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360F***; H302; H317; H412 | |
| reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl) oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione; 1-[3-[(2-ethylhexyl) oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione | reaction mass of: 1,5-bis[(2-ethylhexyl)amino]-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[3-[(2-ethylhexyl)oxy]propyl]amino-9,10-anthracenedione; 1,5-bis[3-[(2-ethylhexyl) oxy]propyl]amino-9,10-anthracenedione; 1-[(2-ethylhexyl)amino]-5-[(3-methoxypropyl)amino]-9,10-anthracene dione; 1-[3-[(2-ethylhexyl) oxy]propyl]amino-5-[(3-methoxypropyl)amino]-9,10-anthracenedione; 1,5-bis[(3-methyloxypropyl)amino]-9,10-anthracenedione | 165038-51-7 | 426-050-7 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone | 4-(3-triethoxysilylpropoxy)-2-hydroxybenzophenone | 79876-59-8 | 431-490-8 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone | 1-(4-(trans-4-ethylcyclohexyl)phenyl)ethanone | 426-460-6 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| 1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone | 1-(4-(trans-4-pentylcyclohexyl)phenyl)ethanone | 78531-59-6 | 426-830-7 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| 3,4,3’, 4’-tetraphenyl-1,1’-ethandiylbispyrol-2,5-dione | 3,4,3’, 4’-tetraphenyl-1,1’-ethandiylbispyrol-2,5-dione | 226065-73-2 | 431-500-0 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| 1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone | 1-(4-(trans-4-butylcyclohexyl)phenyl)ethanone | 83626-30-6 | 427-320-7 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| 8-azaspiro[4.5]decane-7,9-dione | 8-azaspiro[4.5]decane-7,9-dione | 1075-89-4 | 427-770-4 | substance | Acute Tox. 3 *; Aquatic Chronic 2 | Hazard statement codes: H301; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H411 | |
| 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone | 1,1,1,2,2,4,5,5,5-nonafluoro-4-(trifluoromethyl)-3-pentanone | 756-13-8 | 436-710-6 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| 2-(4-methyl-3-pentenyl)anthraquinone | 2-(4-methyl-3-pentenyl)anthraquinone | 71308-16-2 | 428-320-1 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H302; H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317; H413 | |
| 5-ethoxy-5H-furan-2-one | 5-ethoxy-5H-furan-2-one | 2833-30-9 | 428-330-4 | substance | Skin Corr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; STOT RE 2 *; Skin Sens. 1 | Hazard statement codes: H314; H312; H302; H373**; H317. Labelling pictogram and signal word: GHS05; GHS08; GHS07; Dgr. Labelling hazard statements: H314; H312; H302; H373**; H317 | |
| 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one | 5-amino-6-methyl-1,3-dihydrobenzoimidazol-2-one | 67014-36-2 | 428-410-9 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| (4aR*, 8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one | (4aR*, 8aR*)-4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-one | 1668-86-6 | 428-690-2 | substance | Acute Tox. 4 *; Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H302; H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H412 | |
| 1-[4-(4-benzoylphenylsulfanyl)phenyl]- 2-methyl-2-(4-methylphenylsulfonyl) propan-1-one | 1-[4-(4-benzoylphenylsulfanyl)phenyl]- 2-methyl-2-(4-methylphenylsulfonyl) propan-1-one | 272460-97-6 | 429-040-0 | substance | Eye Dam. 1; Aquatic Chronic 4 | Hazard statement codes: H318; H413. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H413 | |
| 4,4’, 5,5’, 6,6’, 7,7’-octachloro-(2,2’)biisoindolyl-1,1’, 3,3’-tetraone | 4,4’, 5,5’, 6,6’, 7,7’-octachloro-(2,2’)biisoindolyl-1,1’, 3,3’-tetraone | 67887-47-2 | 429-150-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| profoxydim (ISO); 2-{](EZ)-1-[}(2RS)-2-(4-chlorophenoxy)propoxyimino{] butyl[}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one | profoxydim (ISO); 2-{](EZ)-1-[}(2RS)-2-(4-chlorophenoxy)propoxyimino{] butyl[}-3-hydroxy-5-(thian-3-yl)cyclohex-2-en-1-one | 139001-49-3 | substance | Carc. 2; Repr. 2; Skin Sens. 1 | Hazard statement codes: H351; H361d; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H351; H361d; H317 | ||
| tepraloxydim (ISO); (RS)-(EZ)-2-{]1-[}(2E)-3-chloroallyloxyimino{]propyl[}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one | tepraloxydim (ISO); (RS)-(EZ)-2-{]1-[}(2E)-3-chloroallyloxyimino{]propyl[}-3-hydroxy-5-perhydropyran-4-ylcyclohex-2-en-1-one | 149979-41-9 | substance | Carc. 2; Repr. 2 | Hazard statement codes: H351; H361fd. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H351; H361fd | ||
| 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one | 2,6-bis(1,1-dimethylethyl)-4-(phenylenemethylene)cyclohexa-2,5-dien-1-one | 7078-98-0 | 429-460-4 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | |
| N-(1,3-dimethylbutyl)-N’-(phenyl)-1,4-benzoquinonediimine | N-(1,3-dimethylbutyl)-N’-(phenyl)-1,4-benzoquinonediimine | 52870-46-9 | 429-640-2 | substance | Eye Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H319; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H410 | |
| (E)-3-methyl-5-cyclopentadecen-1-one | (E)-3-methyl-5-cyclopentadecen-1-one | 429-900-5 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | ||
| 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one | 2,5-dihydroxy-5-methyl-3-(morpholin-4-yl)-2-cyclopenten-1-one | 114625-74-0 | 430-170-5 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| (+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1’-(cyclohex-2’-en-4’-one) | (+)-(1S, 2S, 3S, 5R)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-spiro-1’-(cyclohex-2’-en-4’-one) | 133636-82-5 | 430-460-1 | substance | Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H314; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H314; H317; H410 | |
| 3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one | 3-(2-bromopropionoyl)-4,4-dimethyl-1,3-oxazolan-2-one | 114341-88-7 | 430-820-8 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H373**; H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H373**; H315; H318; H317; H410 | |
| 4-hexadecyl-1-phenylpyrazolidin-3-one | 4-hexadecyl-1-phenylpyrazolidin-3-one | 430-840-7 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | ||
| 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione | 1-cyclopropyl-3-(2-methylthio-4-trifluoromethylphenyl)-1,3-propanedione | 161462-35-7 | 421-080-7 | substance | STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373**; H410 | |
| 1-benzylimidazolidine-2,4-dione | 1-benzylimidazolidine-2,4-dione | 6777-05-5 | 421-340-1 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 1,4-bis(2,3-dihydroxypropylamino)anthraquinone | 1,4-bis(2,3-dihydroxypropylamino)anthraquinone | 99788-75-7 | 421-470-7 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 2,2’-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione | 2,2’-(1,3-phenylene)bis[5-chloro-1H-isoindole]-1,3(2H)-dione | 148935-94-8 | 422-650-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | 5-amino-[2S-di(methylphenyl)amino]-1,6-diphenyl-4Z-hexen-3-one; (2S, 4Z)-5-amino-2-(dibenzylamino)-1,6-diphenylhex-4-en-3-one | 156732-13-7 | 423-090-7 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone | 4-(1,4-dioxa-spiro[4.5]dec-8-yl)-cyclohexanone | 56309-94-5 | 423-860-2 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione | cyclic 3-(1,2-ethanediylacetale)-estra-5(10),9(11)-diene-3,17-dione | 5571-36-8 | 427-230-8 | substance | Repr. 1B; STOT RE 2 *; Aquatic Chronic 2 | Hazard statement codes: H360F***; H373**; H411. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360F***; H373**; H411 | |
| (6β)-6,19-epoxyandrost-4-ene-3,17-dione | (6β)-6,19-epoxyandrost-4-ene-3,17-dione | 6563-83-3 | 433-490-3 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| androsta-1,4,9(11)-triene-3,17-dione | androsta-1,4,9(11)-triene-3,17-dione | 15375-21-0 | 433-560-3 | substance | Repr. 2 | Hazard statement codes: H361f***. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H361f*** | |
| cyclohexadecanone | cyclohexadecanone | 2550-52-9 | 438-930-8 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| (3S, 6R, 9S, 12R, 15S, 18R, 21S, 24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone | (3S, 6R, 9S, 12R, 15S, 18R, 21S, 24R)-6,18-dibenzyl-3,9,15,21-tetraisobutyl-4,10,12,16,22,24-hexamethyl-1,7,13,19-tetraoxa-4,10,16,22-tetraazacyclo-tetracosane-2,5,8,11,14,17,20,23-octaone | 133413-70-4 | 444-350-6 | substance | Eye Irrit. 2; Aquatic Chronic 4 | Hazard statement codes: H319; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H413 | |
| trans-7,7’-dimethyl-(4H, 4H’)-(2,2’)bi[benzo[1,4]thiazinylidene]-3,3’-dione | trans-7,7’-dimethyl-(4H, 4H’)-(2,2’)bi[benzo[1,4]thiazinylidene]-3,3’-dione | 211387-26-7 | 444-750-0 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| (2-butyl-5-nitrobenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl] methanone | (2-butyl-5-nitrobenzofuran-3-yl) [4-(3-dibutylaminopropoxy)phenyl] methanone | 141645-23-0 | 444-800-1 | substance | Flam. Liq. 3; Acute Tox. 4 *; STOT RE 2 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=10 | Hazard statement codes: H226; H302; H373**; H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS02; GHS05; GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H226; H302; H373**; H315; H318; H317; H410 |
| (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one | (S)-4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one | 124379-29-9 | 444-830-5 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one | 2-hydroxy-1-(4-(4-(2-hydroxy-2-methylpropionyl)benzyl)phenyl)-2-methylpropan-1-one | 474510-57-1 | 444-860-9 | substance | STOT RE 2 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H373**; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H373**; H410 | |
| sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate | sodium 3-(methoxycarbonyl)-4-oxo-3,4,5,6-tetrahydro-2-pyridinolate | 418-410-7 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | ||
| reaction mass of: (1RS, 2SR, 7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one | reaction mass of: (1RS, 2SR, 7SR, 8SR, E) 9 and 10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-10-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one; (1RS, 2SR, 7SR, 8SR, Z)-9-ethylidene-3-oxatricyclo[6.2.1.0(2,7)]undecan-4-one | 434-290-9 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | ||
| abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] avermectin B1a (purity ≥80 %) [2] | abamectin (combination of avermectin B1a and avermectin B1b) (ISO) [1] avermectin B1a (purity ≥80 %) [2] | 71751-41-2 [1] 65195-55-3 [2] | _ [1] 265-610-3 [2] | substance | Repr. 2; Acute Tox. 2; Acute Tox. 1; STOT RE 1; Aquatic Acute 1; Aquatic Chronic 1 | STOT RE 1; | H372: C ≥ 5 % | STOT RE 2; | H373: 0.5 % | ≤C<5 % | M = 10 000 | Hazard statement codes: H361d; H300; H330; H372 (nervous system); H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS09; Dgr. Labelling hazard statements: H361d; H300; H330; H372 (nervous system); H410 |
| acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4- dihydronaphthalen-2-yl acetate | acequinocyl (ISO); 3-dodecyl-1,4-dioxo-1,4- dihydronaphthalen-2-yl acetate | 57960-19-7 | substance | Skin Sens. 1; STOT SE 1; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 000 | Hazard statement codes: H317; H370 (lung) (inhalation); H373 (blood system); H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Dgr. Labelling hazard statements: H317; H370 (lung) (inhalation); H373 (blood system); H410 | |
| sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3- dione | sulcotrione (ISO); 2-[2-chloro-4-(methylsulfonyl)benzoyl]cyclohexane-1,3- dione | 99105-77-8 | substance | Repr. 2; STOT RE 2; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 10 | Hazard statement codes: H361d; H373 (kidneys); H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d; H373 (kidneys); H317; H410 | |
| tralkoxydim (ISO); 2-(N- ethoxypropanimidoyl)- 3-hydroxy-5-mesitylcyclohex-2-en-1-one | tralkoxydim (ISO); 2-(N- ethoxypropanimidoyl)- 3-hydroxy-5-mesitylcyclohex-2-en-1-one | 87820-88-0 | substance | Carc. 2; Acute Tox. 4; Aquatic Chronic 2 | Hazard statement codes: H351; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H302; H411 | ||
| cycloxydim (ISO); 2-(N- ethoxybutanimidoyl)-3- hydroxy-5-(tetrahydro- 2H-thiopyran-3-yl) cyclohex-2-en-1-one | cycloxydim (ISO); 2-(N- ethoxybutanimidoyl)-3- hydroxy-5-(tetrahydro- 2H-thiopyran-3-yl) cyclohex-2-en-1-one | 101205-02-1 | 405-230-9 | substance | Repr. 2 | Hazard statement codes: H361d. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H361d | |
| carvone (ISO); 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [1] d-carvone; (5S)-2-methyl-5- (prop-1-en-2-yl)cyclohex-2-en- 1-one; [2] l-carvone; (5R)-2-methyl-5- (prop-1-en-2-yl)cyclohex-2-en- 1-one [3] | carvone (ISO); 2-methyl-5-(prop-1-en-2-yl)cyclohex-2-en-1-one; [1] d-carvone; (5S)-2-methyl-5- (prop-1-en-2-yl)cyclohex-2-en- 1-one; [2] l-carvone; (5R)-2-methyl-5- (prop-1-en-2-yl)cyclohex-2-en- 1-one [3] | 99-49-0 [1] 2244-16-8 [2] 6485-40-1 [3] | 202-759-5 [1] 218-827-2 [2] 229-352-5 [3] | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| tembotrione (ISO); 2-{2- chloro-4-(methylsulfonyl)-3- [(2,2,2-trifluoroethoxy)methyl] benzoyl}cyclohexane-1,3-dione | tembotrione (ISO); 2-{2- chloro-4-(methylsulfonyl)-3- [(2,2,2-trifluoroethoxy)methyl] benzoyl}cyclohexane-1,3-dione | 335104-84-2 | substance | Repr. 2; STOT RE 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 10 | Hazard statement codes: H361d; H373 (eyes, kidneys, liver); H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361d; H373 (eyes, kidneys, liver) H317; H410 | |
| clethodim (ISO); (5RS)-2- {(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5- [(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex- 2-en-1-one | clethodim (ISO); (5RS)-2- {(1EZ)-1-[(2E)-3-chloroallyloxyimino]propyl}-5- [(2RS)-2-(ethylthio)propyl]-3-hydroxycyclohex- 2-en-1-one | 99129-21-2 | substance | Acute Tox. 4; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317; H412. Supplementary hazard statements: EUH066 | ||
| anthraquinone | anthraquinone | 84-65-1 | 201-549-0 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350’ | |
| (5-chloro-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone | (5-chloro-2-methoxy-4-methyl-3-pyridyl)(4,5,6-trimethoxy-o-tolyl)methanone; pyriofenone | 688046-61-9 | substance | Carc. 2; Aquatic Chronic 1 | M = 1 | Hazard statement codes: H351; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| benzophenone | benzophenone | 119-61-9 | 204-337-6 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone | quinoclamine (ISO); 2-amino-3-chloro-1,4-naphthoquinone | 2797-51-5 | 220-529-2 | substance | Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1A; Aquatic Acute 1; Aquatic Chronic 1 | Oral: | ATE = 500 mg/kg bw | M = 10 | M = 10 | Hazard statement codes: H351; H361d; H302; H373 (blood system); H319; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H361d; H302; H373 (blood system); H319; H317; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| acetone oxime | acetone oxime | 127-06-0 | 204-820-1 | substance | Carc. 1B; Acute Tox. 4; STOT SE 3; STOT RE 2; Eye Dam. 1; Skin Sens. 1 | Dermal: ATE = | 1100 mg/kg bw | Hazard statement codes: H350; H312; H336; H373; (blood; system); H318; H317. Labelling pictogram and signal word: GHS08; GHS07; GHS05; Dgr. Labelling hazard statements: H350; H312; H336; H373; (blood; system); H318; H317. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| (3E)-dec-3-en-2-one | (3E)-dec-3-en-2-one | 18402-84-1 | substance | Acute Tox. 4; Skin Irrit. 2; Aquatic Chronic 2 | inhalation: ATE = 1.5 mg/L (dusts or mists) | Hazard statement codes: H332; H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H315; H411. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 | |
| 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4- (morpholin-4-yl)phenyl]butan-1-one | 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4- (morpholin-4-yl)phenyl]butan-1-one | 119344-86-4 | 438-340-0 | substance | Repr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | M=1 | M=1 | Hazard statement codes: H360Df; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360Df; H410. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| 1-hydroxy-4-(p-toluidino)anthraquinone (Solvent Violet 13) | 1-hydroxy-4-(p-toluidino)anthraquinone (Solvent Violet 13) | 81-48-1 | 201-353-5 | substance | Skin Sens. 1 B | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| 1,2-dihydroxy-9,10-dihydroanthracene-9,10-dione (Pigment Red 83) | 1,2-dihydroxy-9,10-dihydroanthracene-9,10-dione (Pigment Red 83) | 72-48-0 | 200-782-5 | substance | Skin Sens. 1 B | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317. Date of Secretary of State decision: 2025-09-12. Date of entry into legal effect: 2025-09-23. Final compliance date: 2027-03-23 | |
| formic acid ... % | formic acid ... % | 64-18-6 | 200-579-1 | substance | Flam. Liq. 3; Met. Corr. 1; Acute Tox. 4; Acute Tox. 3; Skin Corr. 1A; Eye Dam. 1 | Flam. Liq. 3; H226: C > 85% | Oral: ATE = 500 mg/kg bw | inhalation: ATE = 7.4 mg/l | (vapours) | Skin Corr. 1A; H314: C ≥ 90% | Skin Corr. 1B; 314: 10% ≤ C | < 90% | Skin Irrit. 2; H315: 2% ≤ C < 10% | Eye Dam. 1; H318: C ≥ 10% | Eye Irrit. 2; H319: 2% ≤ C < 10% | Hazard statement codes: H226; H290; H302; H331; H314; H318. Labelling pictogram and signal word: GHS02; GHS05; GHS06; Dgr. Labelling hazard statements: H226; H290; H302; H331; H314. Supplementary hazard statements: EUH071. Notes: B. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| acetic acid ... % | acetic acid ... % | 64-19-7 | 200-580-7 | substance | Flam. Liq. 3; Skin Corr. 1A | Skin Corr. 1A; | H314: C ≥ 90 % | Skin Corr. 1B; | H314: 25 % ≤ C | < 90 % | Skin Irrit. 2; | H315: 10 % ≤ C | < 25 % | Eye Irrit. 2; H319: | 10 % ≤ C < 25 % | Hazard statement codes: H226; H314. Labelling pictogram and signal word: GHS02; GHS05; Dgr. Labelling hazard statements: H226; H314. Notes: B |
| chloroacetic acid | chloroacetic acid | 79-11-8 | 201-178-4 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Skin Corr. 1B; Aquatic Acute 1 | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H331; H311; H301; H314; H400. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H314; H400 |
| TCA (ISO); trichloroacetic acid | TCA (ISO); trichloroacetic acid | 76-03-9 | 200-927-2 | substance | Skin Corr. 1A; Aquatic Acute 1; Aquatic Chronic 1 | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H314; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H314; H410 |
| TCA-sodium (ISO); sodium trichloroacetate | TCA-sodium (ISO); sodium trichloroacetate | 650-51-1 | 211-479-2 | substance | STOT SE 3; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H335; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H335; H410 | |
| oxalic acid | oxalic acid | 144-62-7 | 205-634-3 | substance | Acute Tox. 4 *; Acute Tox. 4 * | * | Hazard statement codes: H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302. Notes: A |
| salts of oxalic acid with the exception of those specified elsewhere in this Annex | salts of oxalic acid with the exception of those specified elsewhere in this Annex | substance | Acute Tox. 4 *; Acute Tox. 4 * | * | Hazard statement codes: H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302 | ||
| acetic anhydride | acetic anhydride | 108-24-7 | 203-564-8 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Skin Corr. 1B; | H314: C ≥ 25 % | Skin Irrit. 2; | H315: 5 % ≤ C | < 25 % | Eye Dam. 1; | H318: 5 % ≤ C | < 25 % | Eye Irrit. 2; H319: | 1 % ≤ C < 5 % | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H226; H332; H302; H314. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H332; H302; H314 |
| phthalic anhydride | phthalic anhydride | 85-44-9 | 201-607-5 | substance | Acute Tox. 4 *; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H302; H335; H315; H318; H334; H317. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H302; H335; H315; H318; H334; H317 | |
| propionic anhydride | propionic anhydride | 123-62-6 | 204-638-2 | substance | Skin Corr. 1B | Skin Corr. 1B; | H314: C ≥ 25 % | Skin Irrit. 2; | H315: 10 % ≤ C | < 25 % | Eye Irrit. 2; H319: | 10 % ≤ C < 25 % | Hazard statement codes: H314. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314 |
| acetyl chloride | acetyl chloride | 75-36-5 | 200-865-6 | substance | Flam. Liq. 2; Skin Corr. 1B | Hazard statement codes: H225; H314. Labelling pictogram and signal word: GHS02; GHS05; Dgr. Labelling hazard statements: H225; H314. Supplementary hazard statements: EUH014 | |
| benzoyl chloride | benzoyl chloride | 98-88-4 | 202-710-8 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H332; H312; H302; H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H332; H312; H302; H314; H317 | |
| dimethyl carbonate | dimethyl carbonate | 616-38-6 | 210-478-4 | substance | Flam. Liq. 2 | Hazard statement codes: H225. Labelling pictogram and signal word: GHS02; Dgr. Labelling hazard statements: H225 | |
| methyl formate | methyl formate | 107-31-3 | 203-481-7 | substance | Flam. Liq. 1; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H224; H332; H302; H319; H335. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H224; H332; H302; H319; H335 | |
| ethyl formate | ethyl formate | 109-94-4 | 203-721-0 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H225; H332; H302; H319; H335. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H332; H302; H319; H335 | |
| propyl formate; [1] isopropyl formate [2] | propyl formate; [1] isopropyl formate [2] | 110-74-7 [1] 625-55-8 [2] | 203-798-0 [1] 210-901-2 [2] | substance | Flam. Liq. 2; Eye Irrit. 2; STOT SE 3; STOT SE 3 | Hazard statement codes: H225; H319; H335; H336. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H319; H335; H336. Notes: C | |
| butyl formate; [1] tert-butyl formate; [2] isobutyl formate [3] | butyl formate; [1] tert-butyl formate; [2] isobutyl formate [3] | 592-84-7 [1] 762-75-4 [2] 542-55-2 [3] | 209-772-5 [1] 212-105-0 [2] 208-818-1 [3] | substance | Flam. Liq. 2; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H225; H319; H335. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H319; H335. Notes: C | |
| isopentyl formate; [1] 2-methylbutyl formate [2] | isopentyl formate; [1] 2-methylbutyl formate [2] | 110-45-2 [1] 35073-27-9 [2] | 203-769-2 [1] 252-343-2 [2] | substance | Flam. Liq. 2; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H225; H319; H335. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H319; H335. Notes: C | |
| methyl chloroformate | methyl chloroformate | 79-22-1 | 201-187-3 | substance | Flam. Liq. 2; Acute Tox. 2 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H225; H330; H312; H302; H314. Labelling pictogram and signal word: GHS02; GHS06; GHS05; Dgr. Labelling hazard statements: H225; H330; H312; H302; H314 | |
| ethyl chloroformate | ethyl chloroformate | 541-41-3 | 208-778-5 | substance | Flam. Liq. 2; Acute Tox. 2 *; Acute Tox. 4 *; Skin Corr. 1B | Hazard statement codes: H225; H330; H302; H314. Labelling pictogram and signal word: GHS02; GHS06; GHS05; Dgr. Labelling hazard statements: H225; H330; H302; H314 | |
| methyl acetate | methyl acetate | 79-20-9 | 201-185-2 | substance | Flam. Liq. 2; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H225; H319; H336. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H319; H336. Supplementary hazard statements: EUH066 | |
| ethyl acetate | ethyl acetate | 141-78-6 | 205-500-4 | substance | Flam. Liq. 2; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H225; H319; H336. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H319; H336. Supplementary hazard statements: EUH066 | |
| vinyl acetate | vinyl acetate | 108-05-4 | 203-545-4 | substance | Flam. Liq. 2; Carc. 2; Acute Tox. 4; STOT SE 3 | Hazard statement codes: H225; H351; H332; H335. Labelling pictogram and signal word: GHS02; GHS08; GHS07; Dgr. Labelling hazard statements: H225; H351; H332; H335. Notes: D | |
| propyl acetate; [1] isopropyl acetate [2] | propyl acetate; [1] isopropyl acetate [2] | 109-60-4 [1] 108-21-4 [2] | 203-686-1 [1] 203-561-1 [2] | substance | Flam. Liq. 2; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H225; H319; H336. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H319; H336. Supplementary hazard statements: EUH066. Notes: C | |
| n-butyl acetate | n-butyl acetate | 123-86-4 | 204-658-1 | substance | Flam. Liq. 3; STOT SE 3 | Hazard statement codes: H226; H336. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H336. Supplementary hazard statements: EUH066 | |
| sec-butyl acetate; [1] isobutyl acetate; [2] tert-butyl acetate [3] | sec-butyl acetate; [1] isobutyl acetate; [2] tert-butyl acetate [3] | 105-46-4 [1] 110-19-0 [2] 540-88-5 [3] | 203-300-1 [1] 203-745-1 [2] 208-760-7 [3] | substance | Flam. Liq. 2 | Hazard statement codes: H225. Labelling pictogram and signal word: GHS02; Dgr. Labelling hazard statements: H225. Supplementary hazard statements: EUH066. Notes: C | |
| methyl propionate | methyl propionate | 554-12-1 | 209-060-4 | substance | Flam. Liq. 2; Acute Tox. 4 * | Hazard statement codes: H225; H332. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H332 | |
| ethyl propionate | ethyl propionate | 105-37-3 | 203-291-4 | substance | Flam. Liq. 2 | Hazard statement codes: H225. Labelling pictogram and signal word: GHS02; Dgr. Labelling hazard statements: H225 | |
| n-butyl propionate; [1] sec-butyl propionate; [2] iso-butyl propionate [3] | n-butyl propionate; [1] sec-butyl propionate; [2] iso-butyl propionate [3] | 590-01-2 [1] 591-34-4 [2] 540-42-1 [3] | 209-669-5 [1] - [2] 208-746-0 [3] | substance | Flam. Liq. 3 | Hazard statement codes: H226. Labelling pictogram and signal word: GHS02; Wng. Labelling hazard statements: H226. Notes: C | |
| propyl propionate | propyl propionate | 106-36-5 | 203-389-7 | substance | Flam. Liq. 3; Acute Tox. 4 * | Hazard statement codes: H226; H332. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H332 | |
| butyl butyrate | butyl butyrate | 109-21-7 | 203-656-8 | substance | Flam. Liq. 3 | Hazard statement codes: H226. Labelling pictogram and signal word: GHS02; Wng. Labelling hazard statements: H226. Notes: C | |
| ethyl acrylate | ethyl acrylate | 140-88-5 | 205-438-8 | substance | Flam. Liq. 2; Acute Tox. 3; Acute Tox. 4; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2; Skin Sen. 1 | inhalation: ATE = 9 mg/L (vapours) | dermal: ATE = 1800 mg/kg bw | oral: ATE = 1120 mg/kg bw | Eye Irrit. 2; H319: C ≥ 5 % | STOT SE 3; H335: C ≥ 5 % | Skin Irrit. 2; H315: C ≥ 5 % | Hazard statement codes: H225; H331; H312; H302; H335; H315; H319; H317. Labelling pictogram and signal word: GHS06; GHS02; Dgr. Labelling hazard statements: H225; H331; H312; H302; H335; H315; H319; H317. Notes: D. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| n-butyl methacrylate | n-butyl methacrylate | 97-88-1 | 202-615-1 | substance | Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H226; H319; H335; H315; H317. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H319; H335; H315; H317. Notes: D | |
| methyl acrylate; methyl propenoate | methyl acrylate; methyl propenoate | 96-33-3 | 202-500-6 | substance | Flam. Liq. 2; Acute Tox. 3; Acute Tox. 4; Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Irrit. 2; Skin Sen. 1 | inhalation: ATE = 3 mg/L (vapours) | dermal: ATE = 1100 mg/kg bw | oral: ATE = 500 mg/kg bw | Hazard statement codes: H225; H331; H312; H302; H335; H315; H319; H317. Labelling pictogram and signal word: GHS02; GHS06; Dgr. Labelling hazard statements: H225; H331; H312; H302; H335; H315; H319; H317. Notes: D. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate | methyl methacrylate; methyl 2-methylprop-2-enoate; methyl 2-methylpropenoate | 80-62-6 | 201-297-1 | substance | Flam. Liq. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H225; H335; H315; H317. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H335; H315; H317. Notes: D | |
| 2-methoxyethyl acetate; methylglycol acetate | 2-methoxyethyl acetate; methylglycol acetate | 110-49-6 | 203-772-9 | substance | Repr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H360FD; H332; H312; H302. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360FD; H332; H312; H302 | |
| 2-ethoxyethyl acetate; ethylglycol acetate | 2-ethoxyethyl acetate; ethylglycol acetate | 111-15-9 | 203-839-2 | substance | Flam. Liq. 3; Repr. 1B; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H226; H360FD; H332; H312; H302. Labelling pictogram and signal word: GHS02; GHS08; GHS07; Dgr. Labelling hazard statements: H226; H360FD; H332; H312; H302 | |
| 2-butoxyethyl acetate; butylglycol acetate | 2-butoxyethyl acetate; butylglycol acetate | 112-07-2 | 203-933-3 | substance | Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H332; H312. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312 | |
| 2,4-D (ISO); 2,4-dichlorophenoxyacetic acid | 2,4-D (ISO); 2,4-dichlorophenoxyacetic acid | 94-75-7 | 202-361-1 | substance | Acute Tox. 4 *; STOT SE 3; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H302; H335; H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H335; H318; H317; H412 | |
| salts of 2,4-D | salts of 2,4-D | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H317; H411. Notes: A | |||
| 2,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid | 2,4,5-T (ISO); 2,4,5-trichlorophenoxy acetic acid | 93-76-5 | 202-273-3 | substance | Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H335; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H335; H315; H410 | |
| salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid | salts and esters of 2,4,5-T; salts and esters of 2,4,5-trichlorophenoxy acetic acid | substance | Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H335; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H335; H315; H410. Notes: A | |||
| dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid | dicamba (ISO); 2,5-dichloro-6-methoxybenzoic acid; 3,6-dichloro-2-methoxybenzoic acid | 1918-00-9 | 217-635-6 | substance | Acute Tox. 4; Acute Tox. 4; Eye Dam. 1; STOT SE 3; STOT SE 3; Aquatic Acute 1; Aquatic Chronic 2 | inhalation: ATE = 4.0 mg/L (dusts and mists) | oral: ATE = 1500 mg/kg bw | M = 1 | Hazard statement codes: H332; H302; H318; H335; H336; H400; H411. Labelling pictogram and signal word: GHS07; GHS05; GHS09; Dgr. Labelling hazard statements: H332; H302; H318; H335; H336; H410. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1] potassium 3,6-dichloro-o-anisate [2] | 3,6-dichloro-o-anisic acid, compound with dimethylamine (1:1); [1] potassium 3,6-dichloro-o-anisate [2] | 2300-66-5 [1] 10007-85-9 [2] | 218-951-7 [1] 233-002-7 [2] | substance | Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H412 | |
| dichlorprop (ISO); 2-(2,4-dichlorophenoxy) propionic acid | dichlorprop (ISO); 2-(2,4-dichlorophenoxy) propionic acid | 120-36-5 | 204-390-5 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H312; H302; H315; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H315; H318 | |
| salts of dichlorprop | salts of dichlorprop | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H332; H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H312; H302. Notes: A | |||
| fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid | fenoprop (ISO); 2-(2,4,5-trichlorophenoxy)propionic acid | 93-72-1 | 202-271-2 | substance | Acute Tox. 4 *; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H315; H410 | |
| salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid | salts of fenoprop; salts of 2-(2,4,5-trichlorophenoxy)propionic acid | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H312; H302; H410. Notes: A | |||
| mecoprop (ISO); 2-(4-chloro-o-tolyloxy) propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid;[1] 2-(4-chloro-2-methylphenoxy)propionic acid [2] | mecoprop (ISO); 2-(4-chloro-o-tolyloxy) propionic acid; (RS)-2-(4-chloro-o-tolyloxy)propionic acid;[1] 2-(4-chloro-2-methylphenoxy)propionic acid [2] | 7085-19-0 [1] 708519-0 [2] | 230-386-8 [1] 202-264-4 [2] | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | M=100 | Hazard statement codes: H302; H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H315; H318; H410 |
| salts of mecoprop | salts of mecoprop | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H315; H318; H410. Notes: A | |||
| MCPA (ISO); 4-chloro-o-tolyloxyacetic acid | MCPA (ISO); 4-chloro-o-tolyloxyacetic acid | 94-74-6 | 202-360-6 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H315; H318; H410 | |
| salts and esters of MCPA | salts and esters of MCPA | substance | Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H332; H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H332; H312; H302; H410. Notes: A | |||
| MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid | MCPB (ISO); 4-(4-chloro-o-tolyloxy) butyric acid | 94-81-5 | 202-365-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| salts and esters of MCPB | salts and esters of MCPB | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302. Notes: A | |||
| endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate | endothal-sodium (ISO); disodium 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylate | 129-67-9 | 204-959-8 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H301; H312; H319; H335; H315. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H301; H312; H319; H335; H315 | |
| warfarin (ISO); 4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1] (S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2] (R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3] | warfarin (ISO); 4-hydroxy-3-(3-oxo-1- phenylbutyl)-2H-chromen-2-one; [1] (S)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone; [2] (R)-4-hydroxy-3-(3-oxo- 1-phenylbutyl)-2-benzopyrone [3] | 81-81-2 [1] 5543-57-7 [2] 5543-58-8 [3] | 201-377-6 [1] 226-907-3 [2] 226-908-9 [3] | substance | Repr. 1A; Acute Tox. 1; Acute Tox. 1; Acute Tox. 2; STOT RE 1; Aquatic Chronic 2 | Repr. 1A; H360D: | C ≥ 0.003 % | STOT RE 1; H372 (blood): C ≥ 0.5 % | STOT RE 2; H373 (blood): 0.05 % ≤ C < 0.5 %’ | Hazard statement codes: H360D; H330; H310; H300; H372 (blood); H411. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H360D; H330; H310; H300; H372 (blood); H411 |
| coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin | coumachlor (ISO); 3-[1-(4-chlorophenyl)-3-oxobutyl]-4-hydroxycoumarin | 81-82-3 | 201-378-1 | substance | STOT RE 2 *; Aquatic Chronic 3 | Hazard statement codes: H373 **; H412. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H373 **; H412 | |
| coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin | coumafuryl (ISO); fumarin; (RS)-3-(1-(2-furyl)-3-oxobutyl)4-hydroxycoumarin; 4-hydroxy-3-[3-oxo-1-(2-furyl) butyl]coumarin | 117-52-2 | 204-195-5 | substance | Acute Tox. 3 *; STOT RE 1; Aquatic Chronic 3 | Hazard statement codes: H301; H372 **; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H301; H372 **; H412 | |
| coumatetralyl (ISO); 4- hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl) coumarin | coumatetralyl (ISO); 4- hydroxy-3-(1,2,3,4-tetrahydro-1-naphthyl) coumarin | 5836-29-3 | 227-424-0 | substance | Repr. 1B; Acute Tox. 2; Acute Tox. 3; Acute Tox. 2; STOT RE 1; Aquatic Chronic 1 | Repr. 1B; H360D: C | ≥ 0.003 % | STOT RE 1; H372 (blood): C ≥ 1.0 % | STOT RE 2; H373 (blood): 0.1 % ≤ C < 1.0 % | M = 10 | Hazard statement codes: H360D; H330; H311; H300; H372 (blood); H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H360D; H330; H311; H300; H372 (blood); H410 |
| dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) | dicoumarol; 4,4'-dihydroxy-3,3'-methylenebis(2H-chromen-2-one) | 66-76-2 | 200-632-9 | substance | STOT RE 1; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H372 **; H302; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H372 **; H302; H411 | |
| acrylic acid; prop-2-enoic acid | acrylic acid; prop-2-enoic acid | 79-10-7 | 201-177-9 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A; Aquatic Acute 1 | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H226; H332; H312; H302; H314; H400. Labelling pictogram and signal word: GHS02; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H226; H332; H312; H302; H314; H400. Notes: D |
| n-butyl acrylate | n-butyl acrylate | 141-32-2 | 205-480-7 | substance | Flam. Liq. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H226; H319; H335; H315; H317. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H319; H335; H315; H317. Notes: D | |
| isobutyric acid | isobutyric acid | 79-31-2 | 201-195-7 | substance | Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302 | |
| benzyl chloroformate | benzyl chloroformate | 501-53-1 | 207-925-0 | substance | Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H314; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H314; H410 |
| bromoacetic acid | bromoacetic acid | 79-08-3 | 201-175-8 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Skin Corr. 1A; Skin Sens. 1; Aquatic Acute 1 | Hazard statement codes: H331; H311; H301; H314; H317; H400. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H314; H317; H400 | |
| dichloroacetic acid | dichloroacetic acid | 79-43-6 | 201-207-0 | substance | Skin Corr. 1A; Aquatic Acute 1 | Hazard statement codes: H314; H400. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H314; H400 | |
| dichloroacetyl chloride | dichloroacetyl chloride | 79-36-7 | 201-199-9 | substance | Skin Corr. 1A; Aquatic Acute 1 | Hazard statement codes: H314; H400. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H314; H400 | |
| iodoacetic acid | iodoacetic acid | 64-69-7 | 200-590-1 | substance | Acute Tox. 3 *; Skin Corr. 1A | Hazard statement codes: H301; H314. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H301; H314 | |
| ethyl bromoacetate | ethyl bromoacetate | 105-36-2 | 203-290-9 | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 * | Hazard statement codes: H330; H310; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H330; H310; H300 | |
| ethyl chloroacetate | ethyl chloroacetate | 105-39-5 | 203-294-0 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1 | Hazard statement codes: H331; H311; H301; H400. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H400 | |
| ethyl methacrylate | ethyl methacrylate | 97-63-2 | 202-597-5 | substance | Flam. Liq. 2; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H225; H319; H335; H315; H317. Labelling pictogram and signal word: GHS02; GHS07; Dgr. Labelling hazard statements: H225; H319; H335; H315; H317. Notes: D | |
| 2-hydroxyethyl acrylate | 2-hydroxyethyl acrylate | 818-61-1 | 212-454-9 | substance | Acute Tox. 3 *; Skin Corr. 1B; Skin Sens. 1; Aquatic Acute 1 | * | Skin Sens. 1; | H317: C ≥ 0.2 % | Hazard statement codes: H311; H314; H317; H400. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H311; H314; H317; H400. Notes: D |
| 4-CPA (ISO); 4-chlorophenoxyacetic acid | 4-CPA (ISO); 4-chlorophenoxyacetic acid | 122-88-3 | 204-581-3 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| chlorfenac(ISO); 2,3,6-trichlorophenylacetic acid | chlorfenac(ISO); 2,3,6-trichlorophenylacetic acid | 85-34-7 | 201-599-3 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate | chlorfenprop-methyl; methyl 2-chloro-3-(4-chlorophenyl)propionate | 14437-17-3 | 238-413-5 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H410 | |
| dodine(ISO); dodecylguanidinium acetate | dodine(ISO); dodecylguanidinium acetate | 2439-10-3 | 219-459-5 | substance | Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H319; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H319; H315; H410 | |
| erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate | erbon (ISO); 2-(2,4,5-trichlorophenoxy)ethyl 2,2-dichloropropionate | 136-25-4 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | ||
| fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate | fluenetil (ISO); 2-fluoroethyl biphenyl-4-ylacetate | 4301-50-2 | substance | Acute Tox. 1; Acute Tox. 2 * | Hazard statement codes: H310; H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H310; H300 | ||
| kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo [5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate | kelevan (ISO); ethyl 5-(perchloro-5-hydroxypentacyclo [5,3,0,02,6,03,9,04,8]decan-5-yl)-4-oxopentanoate; ethyl 5-(1,2,3,5,6,7,8,9,10,10-decachloro-4-hydroxypentacyclo(5,2,1,02,6,03,9,05,8)dec-4-yl)-4-oxovalerate | 4234-79-1 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H311; H302; H411. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H311; H302; H411 | ||
| chloroacetyl chloride | chloroacetyl chloride | 79-04-9 | 201-171-6 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; STOT RE 1; Skin Corr. 1A; Aquatic Acute 1 | Hazard statement codes: H331; H311; H301; H372 **; H314; H400. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H331; H311; H301; H372 **; H314; H400. Supplementary hazard statements: EUH014; EUH029 | |
| fluoroacetic acid | fluoroacetic acid | 144-49-0 | 205-631-7 | substance | Acute Tox. 2 *; Aquatic Acute 1 | Hazard statement codes: H300; H400. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H300; H400 | |
| fluoroacetates, soluble | fluoroacetates, soluble | substance | Acute Tox. 2 *; Aquatic Acute 1 | Hazard statement codes: H300; H400. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H300; H400. Notes: A | |||
| 2,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid | 2,4-DB (ISO); 4-(2,4-dichlorophenoxy)butyric acid | 94-82-6 | 202-366-9 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| salts of 2,4-DB | salts of 2,4-DB | substance | Acute Tox. 4 *; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H411. Notes: A | |||
| benzyl benzoate | benzyl benzoate | 120-51-4 | 204-402-9 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| diallyl phthalate | diallyl phthalate | 131-17-9 | 205-016-3 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| methacrylic acid; 2-methylpropenoic acid | methacrylic acid; 2-methylpropenoic acid | 79-41-4 | 201-204-4 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H312; H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H314. Notes: D |
| propionic acid ... % | propionic acid ... % | 79-09-4 | 201-176-3 | substance | Skin Corr. 1B | Skin Corr. 1B; | H314: C ≥ 25 % | Skin Irrit. 2; | H315: 10 % ≤ C | < 25 % | Eye Irrit. 2; H319: | 10 % ≤ C < 25 % | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H314. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314. Notes: B |
| thioglycolic acid | thioglycolic acid | 68-11-1 | 200-677-4 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Skin Corr. 1B | * | Hazard statement codes: H331; H311; H301; H314. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H331; H311; H301; H314 |
| trifluoroacetic acid . . . % | trifluoroacetic acid . . . % | 76-05-1 | 200-929-3 | substance | Acute Tox. 4 *; Skin Corr. 1A; Aquatic Chronic 3 | * | Hazard statement codes: H332; H314; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H332; H314; H412. Notes: B |
| methyl lactate; [1] methyl (±)-lactate; [2] methyl (R)-lactate; [3] methyl (S)-(-)-lactate [4] | methyl lactate; [1] methyl (±)-lactate; [2] methyl (R)-lactate; [3] methyl (S)-(-)-lactate [4] | 547-64-8 [1] 2155-30-8 [2] 17392-83-5 [3] 27871-49-4 [4] | 208-930-0 [1] 218-449-8 [2] 241-420-6 [3] 248-704-9 [4] | substance | Flam. Liq. 3; Eye Irrit. 2; STOT SE 3 | Hazard statement codes: H226; H319; H335. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H319; H335. Notes: C | |
| propionyl chloride | propionyl chloride | 79-03-8 | 201-170-0 | substance | Flam. Liq. 2; Skin Corr. 1B | Hazard statement codes: H225; H314. Labelling pictogram and signal word: GHS02; GHS05; Dgr. Labelling hazard statements: H225; H314. Supplementary hazard statements: EUH014. Notes: B D | |
| peracetic acid . . . % | peracetic acid . . . % | 79-21-0 | 201-186-8 | substance | Org. Perox. D; Acute Tox. 2; Acute Tox. 2; Acute Tox. 3; Skin Corr. 1A; Aquatic Acute 1; Aquatic Chronic 1 | inhalation: ATE = 0.2 mg/L (dusts and mists) | dermal: ATE = 60 mg/kg bw | oral: ATE = 80 mg/kg bw | STOT SE 3; H335: C ≥ 1 % | M = 10 | M = 100 | Hazard statement codes: H242; H330; H310; H301; H314; H400; H410. Labelling pictogram and signal word: GHS02; GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H242; H330; H310; H301; H314; H410. Supplementary hazard statements: EUH071. Notes: B D T. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| maleic acid | maleic acid | 110-16-7 | 203-742-5 | substance | Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 | Skin Sens. 1; H317: | C ≥ 0.1 % | Hazard statement codes: H302; H319; H335; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H335; H315; H317 |
| maleic anhydride | maleic anhydride | 108-31-6 | 203-571-6 | substance | Acute Tox. 4; STOT RE 1; Skin Corr. 1B; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1A | Skin Sens. 1A; H317: | C ≥ 0.001 %’ | Hazard statement codes: H302; H372 (respiratory system) (inhalation); H314; H318; H334; H317. Labelling pictogram and signal word: GHS07; GHS08; GHS05; Dgr. Labelling hazard statements: H302; H372 (respiratory system) (inhalation); H314; H334; H317. Supplementary hazard statements: EUH071 |
| benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride | benzene-1,2,4-tricarboxylic acid 1,2-anhydride; trimellitic anhydride | 552-30-7 | 209-008-0 | substance | STOT SE 3; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H335; H318; H334; H317. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H335; H318; H334; H317 | |
| benzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride | benzene-1,2:4,5-tetracarboxylic dianhydride; benzene-1,2:4,5-tetracarboxylic dianhydride; pyromellitic dianhydride | 89-32-7 | 201-898-9 | substance | Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H318; H334; H317. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H318; H334; H317 | |
| 1,2,3,6-tetrahydrophthalic anhydride; [1] cis-1,2,3,6-tetrahydrophthalic anhydride; [2] 3,4,5,6-tetrahydrophthalic anhydride; [3] tetrahydrophthalic anhydride [4] | 1,2,3,6-tetrahydrophthalic anhydride; [1] cis-1,2,3,6-tetrahydrophthalic anhydride; [2] 3,4,5,6-tetrahydrophthalic anhydride; [3] tetrahydrophthalic anhydride [4] | 85-43-8 [1] 935-79-5 [2] 2426-02-0 [3] 26266-63-7 [4] | 201-605-4 [1] 213-308-7 [2] 219-374-3 [3] 247-570-9 [4] | substance | Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H334; H317; H412. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H318; H334; H317; H412. Notes: C | |
| benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride) | benzophenone-3,3',4,4'-tetracarboxylic dianhydride; 4,4'-carbonyldi(phthalic anhydride) | 2421-28-5 | 219-348-1 | substance | Eye Irrit. 2; STOT SE 3 | Eye Irrit. 2; H319: | C ≥ 1 % | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H319; H335. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H335 |
| 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride | 1,4,5,6,7,7-hexachlorobicyclo [2,2,1]hept-5-ene-2,3-dicarboxylic anhydride chlorendic anhydride | 115-27-5 | 204-077-3 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Skin Irrit. 2; | H315: C ≥ 1 % | Eye Irrit. 2; H319: | C ≥ 1 % | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H319; H335; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H335; H315 |
| cyclohexane-1,2-dicarboxylic anhydride; [1] cis-cyclohexane-1,2-dicarboxylic anhydride; [2] trans-cyclohexane-1,2-dicarboxylic anhydride [3] | cyclohexane-1,2-dicarboxylic anhydride; [1] cis-cyclohexane-1,2-dicarboxylic anhydride; [2] trans-cyclohexane-1,2-dicarboxylic anhydride [3] | 85-42-7 [1] 13149-00-3 [2] 14166-21-3 [3] | 201-604-9 [1] 236-086-3 [2] 238-009-9 [3] | substance | Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H318; H334; H317. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H318; H334; H317. Notes: C | |
| succinic anhydride | succinic anhydride | 108-30-5 | 203-570-0 | substance | Acute Tox. 4; Skin Corr. 1; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H302; H314; H318; H334; H317. Labelling pictogram and signal word: GHS07; GHS05; GHS08; Dgr. Labelling hazard statements: H302; H314; H334; H317. Supplementary hazard statements: EUH071’ | |
| cyclopentane-1,2,3,4-tetracarboxylic dianhydride | cyclopentane-1,2,3,4-tetracarboxylic dianhydride | 6053-68-5 | 227-964-7 | substance | Eye Irrit. 2; STOT SE 3 | Eye Irrit. 2; H319: C ≥ 1 % | STOT SE 3; | H335: C ≥ 1 % | Hazard statement codes: H319; H335. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H335 |
| 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1] 1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] | 8,9,10-trinorborn-5-ene-2,3-dicarboxylic anhydride; [1] 1,2,3,6-tetrahydro-3,6-methanophthalic anhydride; [2] (1α,2α,3β,6β)-1,2,3,6-tetrahydro-3,6-methanophthalic anhydride [3] | 129-64-6 [1] 826-62-0 [2] 2746-19-2 [3] | 204-957-7 [1] 212-557-9 [2] 220-384-5 [3] | substance | Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H318; H334; H317. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H318; H334; H317. Notes: C | |
| 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride | 8,9-dinorborn-5-ene-2,3-dicarboxylic anhydride | 123748-85-6 | substance | Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Resp. Sens. 1 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H302; H319; H335; H315; H334. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H302; H319; H335; H315; H334. Notes: C | |
| 2-ethylhexyl acrylate | 2-ethylhexyl acrylate | 103-11-7 | 203-080-7 | substance | STOT SE 3; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H335; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H335; H315; H317. Notes: D | |
| 2-hydroxy-1-methylethylacrylate; [1] 2-hydroxypropylacrylate; [2] acrylic acid, monoester with propane-1,2- diol [3] | 2-hydroxy-1-methylethylacrylate; [1] 2-hydroxypropylacrylate; [2] acrylic acid, monoester with propane-1,2- diol [3] | 2918-23-2 [1] 999-61-1 [2] 25584-83-2 [3] | 220-852-9 [1] 213-663-8 [2] 247-118-0 [3] | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Skin Corr. 1B; Skin Sens. 1 | * | Skin Sens. 1; | H317: C ≥ 0.2 % | Hazard statement codes: H331; H311; H301; H314; H317. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H331; H311; H301; H314; H317. Notes: C D |
| hexamethylene diacrylate; hexane-1,6-diol diacrylate | hexamethylene diacrylate; hexane-1,6-diol diacrylate | 13048-33-4 | 235-921-9 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H317. Notes: D | |
| pentaerythritol triacrylate | pentaerythritol triacrylate | 3524-68-3 | 222-540-8 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H317. Notes: D | |
| 2-ethyl-2-[[(1-oxoallyl)oxy] methyl]-1,3-propanediyl diacrylate; 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate | 2-ethyl-2-[[(1-oxoallyl)oxy] methyl]-1,3-propanediyl diacrylate; 2,2-bis(acryloyloxymethyl)butyl acrylate; trimethylolpropane triacrylate | 15625-89-5 | 239-701-3 | substance | Carc. 2; Skin Irrit. 2; Eye Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H351; H315; H319; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H315; H319; H317; H410. Notes: D. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| 2,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate | 2,2-dimethyltrimethylene diacrylate; neopentyl glycol diacrylate | 2223-82-7 | 218-741-5 | substance | Acute Tox. 3 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | * | Hazard statement codes: H311; H319; H315; H317. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H311; H319; H315; H317. Notes: D |
| isobutyl methacrylate | isobutyl methacrylate | 97-86-9 | 202-613-0 | substance | Flam. Liq. 3; STOT SE 3; Skin Irrit. 2; Skin Sens. 1B | Hazard statement codes: H226; H335; H315; H317. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H335; H315; H317. Notes: D | |
| ethylene dimethacrylate | ethylene dimethacrylate | 97-90-5 | 202-617-2 | substance | STOT SE 3; Skin Sens. 1 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H335; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H335; H317. Notes: D |
| isobutyl acrylate | isobutyl acrylate | 106-63-8 | 203-417-8 | substance | Flam. Liq. 3; Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H226; H332; H312; H315; H317. Labelling pictogram and signal word: GHS02; GHS07; Wng. Labelling hazard statements: H226; H332; H312; H315; H317. Notes: D | |
| cyclohexyl acrylate | cyclohexyl acrylate | 3066-71-5 | 221-319-3 | substance | STOT SE 3; Skin Irrit. 2; Aquatic Chronic 2 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H335; H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H335; H315; H411. Notes: D |
| 2,3-epoxypropyl acrylate; glycidyl acrylate | 2,3-epoxypropyl acrylate; glycidyl acrylate | 106-90-1 | 203-440-3 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Acute Tox. 3 *; Skin Corr. 1B; Skin Sens. 1 | * | Skin Sens. 1; | H317: C ≥ 0.2 % | Hazard statement codes: H331; H311; H301; H314; H317. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H331; H311; H301; H314; H317. Notes: D |
| 1-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate | 1-methyltrimethylene diacrylate; 1,3-butylene glycol diacrylate | 19485-03-1 | 243-105-9 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H312; H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H314; H317. Notes: D | |
| tetramethylene diacrylate; 1,4-butyleneglycol diacrylate | tetramethylene diacrylate; 1,4-butyleneglycol diacrylate | 1070-70-8 | 213-979-6 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H312; H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H314; H317. Notes: D | |
| 2,2'-oxydiethyl diacrylate; diethylene glycol diacrylate | 2,2'-oxydiethyl diacrylate; diethylene glycol diacrylate | 4074-88-8 | 223-791-6 | substance | Acute Tox. 3 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | * | Skin Sens. 1; | H317: C ≥ 0.2 % | Hazard statement codes: H311; H319; H315; H317. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H311; H319; H315; H317. Notes: D |
| 8,9,10-trinorborn-2-yl acrylate | 8,9,10-trinorborn-2-yl acrylate | 10027-06-2 | substance | Acute Tox. 4 *; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H312; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H315; H317. Notes: D | ||
| pentaerythritol tetraacrylate | pentaerythritol tetraacrylate | 4986-89-4 | 225-644-1 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H317. Notes: D | |
| 2,3-epoxypropyl methacrylate; glycidyl methacrylate | 2,3-epoxypropyl methacrylate; glycidyl methacrylate | 106-91-2 | 203-441-9 | substance | Carc. 1B; Muta. 2; Repr. 1B; Acute Tox. 3; Acute Tox. 4; STOT SE 3; STOT RE 1; Eye Dam. 1; Skin Corr. 1C; Skin Sens. 1 | Hazard statement codes: H350; H341; H360F; H311; H302; H335; H372 (respiratory tract) (inhalation); H318; H314; H317. Labelling pictogram and signal word: GHS08; GHS06; GHS05; Dgr. Labelling hazard statements: H350; H341; H360F; H311; H302; H335; H372 (respiratory tract) (inhalation); H314; H317. Notes: D | |
| 2-hydroxyethyl methacrylate | 2-hydroxyethyl methacrylate | 868-77-9 | 212-782-2 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H317. Notes: D | |
| 2-hydroxypropyl methacrylate; [1] 3-hydroxypropyl methacrylate [2] | 2-hydroxypropyl methacrylate; [1] 3-hydroxypropyl methacrylate [2] | 923-26-2 [1] 2761-09-3 [2] | 213-090-3 [1] 220-426-2 [2] | substance | Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H317. Notes: C D | |
| 2,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate | 2,2'-(ethylenedioxy)diethyl diacrylate; triethylene glycol diacrylate | 1680-21-3 | 216-853-9 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H317. Notes: D | |
| 2-diethylaminoethyl methacrylate | 2-diethylaminoethyl methacrylate | 105-16-8 | 203-275-7 | substance | Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H332; H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H332; H319; H315; H317. Notes: D | |
| 2-tert-butylaminoethyl methacrylate | 2-tert-butylaminoethyl methacrylate | 3775-90-4 | 223-228-4 | substance | Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H317. Notes: D | |
| ethyl lactate; ethyl DL-lactate; [1] ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate [2] | ethyl lactate; ethyl DL-lactate; [1] ethyl (S)-2-hydroxypropionate; ethyl L-lactate; ethyl-(S)-lactate [2] | 97-64-3 [1] 687-47-8 [2] | 202-598-0 [1] 211-694-1 [2] | substance | Flam. Liq. 3; STOT SE 3; Eye Dam. 1 | Hazard statement codes: H226; H335; H318. Labelling pictogram and signal word: GHS02; GHS05; GHS07; Dgr. Labelling hazard statements: H226; H335; H318. Notes: C | |
| pentyl acetate; [1] isopentyl acetate; [2] 1-methylbutyl acetate; [3] 2-methylbutyl acetat; [4] 2(or 3)-methylbutyl acetate [5] | pentyl acetate; [1] isopentyl acetate; [2] 1-methylbutyl acetate; [3] 2-methylbutyl acetat; [4] 2(or 3)-methylbutyl acetate [5] | 628-63-7 [1] 123-92-2 [2] 626-38-0 [3] 624-41-9 [4] 84145-37-9 [5] | 211-047-3 [1] 204-662-3 [2] 210-946-8 [3] 210-843-8 [4] 282-263-3 [5] | substance | Flam. Liq. 3 | Hazard statement codes: H226. Labelling pictogram and signal word: GHS02; Wng. Labelling hazard statements: H226. Supplementary hazard statements: EUH066. Notes: C | |
| isopentyl propionate; [1] pentyl propionate; [2] 2-methylbutyl propionate [3] | isopentyl propionate; [1] pentyl propionate; [2] 2-methylbutyl propionate [3] | 105-68-0 [1] 624-54-4 [2] 2438-20-2 [3] | 203-322-1 [1] 210-852-7 [2] 219-449-0 [3] | substance | Flam. Liq. 3 | Hazard statement codes: H226. Labelling pictogram and signal word: GHS02; Wng. Labelling hazard statements: H226. Notes: C | |
| 2-dimethylaminoethyl methacrylate | 2-dimethylaminoethyl methacrylate | 2867-47-2 | 220-688-8 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2; Skin Sens. 1 | Hazard statement codes: H312; H302; H319; H315; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302; H319; H315; H317. Notes: D | |
| monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex | monoalkyl or monoaryl or monoalkylaryl esters of acrylic acid with the exception of those specified elsewhere in this Annex | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Aquatic Chronic 2 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H319; H335; H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H335; H315; H411. Notes: A | ||
| monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex | monoalkyl or monoaryl or monoalkyaryl esters of methacrylic acid with the exception of those specified elsewhere in this Annex | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H319; H335; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H335; H315. Notes: A | ||
| butyric acid | butyric acid | 107-92-6 | 203-532-3 | substance | Skin Corr. 1B | Hazard statement codes: H314. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314 | |
| butyryl chloride | butyryl chloride | 141-75-3 | 205-498-5 | substance | Flam. Liq. 2; Skin Corr. 1B | Hazard statement codes: H225; H314. Labelling pictogram and signal word: GHS02; GHS05; Dgr. Labelling hazard statements: H225; H314 | |
| methyl acetoacetate | methyl acetoacetate | 105-45-3 | 203-299-8 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| butyl chloroformate; chloroformic acid butyl ester | butyl chloroformate; chloroformic acid butyl ester | 592-34-7 | 209-750-5 | substance | Flam. Liq. 3; Acute Tox. 3 *; Skin Corr. 1B | Hazard statement codes: H226; H331; H314. Labelling pictogram and signal word: GHS02; GHS06; GHS05; Dgr. Labelling hazard statements: H226; H331; H314 | |
| 2-chloropropionic acid | 2-chloropropionic acid | 598-78-7 | 209-952-3 | substance | Acute Tox. 4 *; Skin Corr. 1A | Hazard statement codes: H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314 | |
| isobutyryl chloride | isobutyryl chloride | 79-30-1 | 201-194-1 | substance | Flam. Liq. 2; Skin Corr. 1A | Hazard statement codes: H225; H314. Labelling pictogram and signal word: GHS02; GHS05; Dgr. Labelling hazard statements: H225; H314 | |
| oxydiethylene bis(chloroformate) | oxydiethylene bis(chloroformate) | 106-75-2 | 203-430-9 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H315; H318; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H315; H318; H411 | |
| propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate | propyl chloroformate; chloroformic acid propylester; n-propyl chloroformate | 109-61-5 | 203-687-7 | substance | Flam. Liq. 2; Acute Tox. 3 *; Skin Corr. 1B | Hazard statement codes: H225; H331; H314. Labelling pictogram and signal word: GHS02; GHS06; GHS05; Dgr. Labelling hazard statements: H225; H331; H314 | |
| valeric acid | valeric acid | 109-52-4 | 203-677-2 | substance | Skin Corr. 1B; Aquatic Chronic 3 | Hazard statement codes: H314; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314; H412 | |
| adipic acid | adipic acid | 124-04-9 | 204-673-3 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| methanesulphonic acid | methanesulphonic acid | 75-75-2 | 200-898-6 | substance | Skin Corr. 1B | Hazard statement codes: H314. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314 | |
| fumaric acid | fumaric acid | 110-17-8 | 203-743-0 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| oxalic acid diethylester; diethyl oxalate | oxalic acid diethylester; diethyl oxalate | 95-92-1 | 202-464-1 | substance | Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H302; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319 | |
| guanidinium chloride; guanadine hydrochloride | guanidinium chloride; guanadine hydrochloride | 50-01-1 | 200-002-3 | substance | Acute Tox. 4 *; Eye Irrit. 2; Skin Irrit. 2 | Hazard statement codes: H302; H319; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H315 | |
| urethane (INN); ethyl carbamate | urethane (INN); ethyl carbamate | 51-79-6 | 200-123-1 | substance | Carc. 1B | Hazard statement codes: H350. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H350 | |
| endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid | endothal (ISO); 7-oxabicyclo(2,2,1)heptane-2,3-dicarboxylic acid | 145-73-3 | 205-660-5 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H301; H312; H319; H335; H315. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H301; H312; H319; H335; H315 | |
| propargite (ISO); 2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite | propargite (ISO); 2-(4-tert-butylphenoxy) cyclohexyl prop-2-ynyl sulphite | 2312-35-8 | 219-006-1 | substance | Carc. 2; Acute Tox. 3 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 10 | Hazard statement codes: H351; H331; H315; H318; H400; H410. Labelling pictogram and signal word: GHS06; GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H351; H331; H315; H318; H410 |
| 2,3,6-TBA (ISO); 2,3,6-trichlorobenzoic acid | 2,3,6-TBA (ISO); 2,3,6-trichlorobenzoic acid | 50-31-7 | 200-026-4 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid | benazolin (ISO); 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid | 3813-05-6 | 223-297-0 | substance | Eye Irrit. 2; Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H319; H315; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315; H412 | |
| ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DLalaninate; benzoylprop-ethyl (ISO) | ethyl N-benzoyl-N-(3,4-dichlorophenyl)-DLalaninate; benzoylprop-ethyl (ISO) | 22212-55-1 | 244-845-5 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-6H)-pyran-2-carboxylic acid; blasticidin-s | 3-(3-amino-5-(1-methylguanidino)-1-oxopentylamino-6-(4-amino-2-oxo-2,3-dihydro-pyrimidin-1-yl)-2,3-dihydro-6H)-pyran-2-carboxylic acid; blasticidin-s | 2079-00-7 | substance | Acute Tox. 2 * | Hazard statement codes: H300. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H300 | ||
| chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate | chlorfenson (ISO); 4-chlorophenyl 4-chlorobenzenesulfonate | 80-33-1 | 201-270-4 | substance | Acute Tox. 4 *; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H315; H410 | |
| difenacoum (ISO); 3-(3- biphenyl-4-yl-1,2,3,4- tetrahydro-1-naphthyl)- 4-hydroxycoumarin | difenacoum (ISO); 3-(3- biphenyl-4-yl-1,2,3,4- tetrahydro-1-naphthyl)- 4-hydroxycoumarin | 56073-07-5 | 259-978-4 | substance | Repr. 1B; Acute Tox. 1; Acute Tox. 1; Acute Tox. 1; STOT RE 1; Aquatic Acute 1; Aquatic Chronic 1 | Repr. 1B; H360D: | C ≥ 0.003 % | STOT RE 1; H372 (blood): C ≥ 0.02 % | STOT RE 2; H373 (blood): | 0.002 % ≤ C < 0.02 % | M = 10 | M = 10 | Hazard statement codes: H360D; H330; H310; H300; H372 (blood); H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H360D; H330; H310; H300; H372 (blood); H410 |
| sodium salt of chloroacetic acid; sodium chloroacetate | sodium salt of chloroacetic acid; sodium chloroacetate | 3926-62-3 | 223-498-3 | substance | Acute Tox. 3 *; Skin Irrit. 2; Aquatic Acute 1 | Hazard statement codes: H301; H315; H400. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H301; H315; H400 | |
| chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate | chlorobenzilate (ISO); ethyl 2,2-di(4-chlorophenyl)-2-hydroxyacetate; ethyl 4,4'-dichlorobenzilate | 510-15-6 | 208-110-2 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO) | isobutyl 2-(4-(4-chlorophenoxy)phenoxy)propionate; clofop-isobutyl (ISO) | 51337-71-4 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | ||
| diethanolamine salt of 4-CPA | diethanolamine salt of 4-CPA | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |||
| dalapon; 2,2-dichloropropionic acid; [1] dalapon-sodium; sodium 2,2-dichloropropionate [2] | dalapon; 2,2-dichloropropionic acid; [1] dalapon-sodium; sodium 2,2-dichloropropionate [2] | 75-99-0 [1] 127-20-8 [2] | 200-923-0 [1] 204-828-5 [2] | substance | Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H315; H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H315; H318; H412 | |
| 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid | 3-acetyl-6-methyl-2H-pyran-2,4(3H)-dione; dehydracetic acid | 520-45-6 | 208-293-9 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate | sodium 1-(3,4-dihydro-6-methyl-2,4-dioxo-2H-pyran-3-ylidene)ethonolate; sodium dehydracetate | 4418-26-2 | 224-580-1 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| diclofop-methyl (ISO) methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; | diclofop-methyl (ISO) methyl 2-(4-(2,4-dichlorophenoxy)phenoxy)propionate; methyl (RS)-2-[4-(2,4-dichlorophenoxy)phenoxy]propionate; | 51338-27-3 | 257-141-8 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate | medinoterb acetate (ISO); 6-tert-butyl-3-methyl-2,4-dinitrophenyl acetate | 2487-01-6 | 219-634-6 | substance | Acute Tox. 3 *; Acute Tox. 4 * | Hazard statement codes: H301; H312. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H301; H312 | |
| sodium 3-chloroacrylate | sodium 3-chloroacrylate | 4312-97-4 | substance | Acute Tox. 4 *; Acute Tox. 4 * | Hazard statement codes: H312; H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312; H302 | ||
| dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome | dipropyl 6,7-methylenedioxy-1,2,3,4-tetrahydro-3-methylnaphthalene-1,2-dicarboxylate; propylisome | 83-59-0 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H311; H302; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H311; H302; H410 | ||
| sodium fluoroacetate | sodium fluoroacetate | 62-74-8 | 200-548-2 | substance | Acute Tox. 2 *; Acute Tox. 1; Acute Tox. 2 *; Aquatic Acute 1 | Hazard statement codes: H330; H310; H300; H400. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H310; H300; H400 | |
| bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate | bis(1,2,3-trithiacyclohexyldimethylammonium) oxalate; thiocyclam-oxalate | 31895-22-4 | 250-859-2 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H312; H302; H410 | |
| brodifacoum (ISO); 4-hydroxy-3-(3-(4′- bromo-4-biphenylyl)- 1,2,3,4-tetrahydro-1- naphthyl)coumarin | brodifacoum (ISO); 4-hydroxy-3-(3-(4′- bromo-4-biphenylyl)- 1,2,3,4-tetrahydro-1- naphthyl)coumarin | 56073-10-0 | 259-980-5 | substance | Repr. 1A; Acute Tox. 1; Acute Tox. 1; Acute Tox. 1; STOT RE 1; Aquatic Acute 1; Aquatic Chronic 1 | Repr. 1A; H360D: | C ≥ 0.003 % | STOT RE 1; H372 (blood): C ≥ 0.02 % | STOT RE 2; H373 (blood): | 0.002 % ≤ C < 0.02 % | M = 10 | M = 10 | Hazard statement codes: H360D; H330; H310; H300; H372 (blood); H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H360D; H330; H310; H300; H372 (blood); H410 |
| dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate | dimethyl (3-methyl-4-(5-nitro-3-ethoxycarbonyl-2-thienyl)azo)phenylnitrilodipropionate | 400-460-6 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | ||
| reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate | reaction mass of dodecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate and tetradecyl 3-(2,2,4,4-tetramethyl-21-oxo-7-oxa-3,20-diazadispiro(5,1,11,2)henicosan-20-yl)propionate | 400-580-9 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | ||
| methyl 2-(2-nitrobenzylidene)acetoacetate | methyl 2-(2-nitrobenzylidene)acetoacetate | 39562-27-1 | 400-650-9 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-2Hbenzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly( oxyethylene) | reaction mass of α-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-hydroxypoly(oxyethylene) and α-3-(3-2Hbenzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyl-ω-3-(3-(2H-benzotriazol-2-yl)-5-tert-butyl-4-hydroxyphenyl)propionyloxypoly( oxyethylene) | 400-830-7 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| tribenuron-methyl (ISO); methyl 2-[N-(4-methoxy-6-methyl-1,3,5- triazin-2-yl)-N-methylcarbamoylsulfamoyl] benzoate | tribenuron-methyl (ISO); methyl 2-[N-(4-methoxy-6-methyl-1,3,5- triazin-2-yl)-N-methylcarbamoylsulfamoyl] benzoate | 101200- 48-0 | 401-190-1 | substance | STOT RE 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | M = 100 | M = 100 | Hazard statement codes: H373; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H373; H317; H410 |
| methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate | methyl α-((4,6-dimethoxypyrimidin-2-yl)ureidosulphonyl)-o-toluate | 83055-99-6 | 401-340-6 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| (benzothiazol-2-ylthio)succinic acid | (benzothiazol-2-ylthio)succinic acid | 95154-01-1 | 401-450-4 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| potassium 2-hydroxycarbazole-1-carboxylate | potassium 2-hydroxycarbazole-1-carboxylate | 96566-70-0 | 401-630-2 | substance | Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Aquatic Chronic 3 | Hazard statement codes: H302; H319; H335; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H335; H412 | |
| 3,5-dichloro-2,4-difluorobenzoyl fluoride | 3,5-dichloro-2,4-difluorobenzoyl fluoride | 101513-70-6 | 401-800-6 | substance | Acute Tox. 3 *; Skin Corr. 1B; Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H331; H314; H302; H317; H412. Labelling pictogram and signal word: GHS06; GHS05; Dgr. Labelling hazard statements: H331; H314; H302; H317; H412. Supplementary hazard statements: EUH029 | |
| methyl 3-sulphamoyl-2-thenoate | methyl 3-sulphamoyl-2-thenoate | 402-050-2 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| zinc 2-hydroxy-5-C13-18alkylbenzoate | zinc 2-hydroxy-5-C13-18alkylbenzoate | 402-280-3 | substance | Eye Irrit. 2; Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H319; H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H315; H411 | ||
| S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate | S-(3-trimethoxysilyl)propyl 19-isocyanato-11-(6-isocyanatohexyl)-10,12-dioxo-2,9,11,13-tetraazanonadecanethioate | 85702-90-5 | 402-290-8 | substance | Flam. Liq. 3; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H226; H334; H317. Labelling pictogram and signal word: GHS02; GHS08; Dgr. Labelling hazard statements: H226; H334; H317 | |
| ethyl trans-3-dimethylaminoacrylate | ethyl trans-3-dimethylaminoacrylate | 1117-37-9 | 402-650-4 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid | quinclorac (ISO); 3,7-dichloroquinoline-8-carboxylic acid | 84087-01-4 | 402-780-1 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| bis(2,2,6,6-tetramethyl-4-piperidyl) succinate | bis(2,2,6,6-tetramethyl-4-piperidyl) succinate | 62782-03-0 | 402-940-0 | substance | Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H412 | |
| hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate | hydrogen sodium N-carboxylatoethyl-N-octadec-9-enylmaleamate | 402-970-4 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| trimethylenediaminetetraacetic acid | trimethylenediaminetetraacetic acid | 1939-36-2 | 400-400-9 | substance | Acute Tox. 4 *; Eye Dam. 1 | Hazard statement codes: H302; H318. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H318 | |
| methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) | methyl acrylamidomethoxyacetate (containing ≥ 0,1 % acrylamid) | 77402-03-0 | 401-890-7 | substance | Carc. 1B; Muta. 1B; Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H350; H340; H302; H319. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H350; H340; H302; H319 | |
| isobutyl 3,4-epoxybutyrate | isobutyl 3,4-epoxybutyrate | 100181-71-3 | 401-920-9 | substance | Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H317; H410 | |
| disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate | disodium N-carboxymethyl-N-(2-(2-hydroxyethoxy)ethyl)glycinate | 92511-22-3 | 402-360-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| propylene carbonate | propylene carbonate | 108-32-7 | 203-572-1 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| 2-methoxy-1-methylethyl acetate | 2-methoxy-1-methylethyl acetate | 108-65-6 | 203-603-9 | substance | Flam. Liq. 3 | Hazard statement codes: H226. Labelling pictogram and signal word: GHS02; Wng. Labelling hazard statements: H226 | |
| heptanoic acid | heptanoic acid | 111-14-8 | 203-838-7 | substance | Skin Corr. 1B | Hazard statement codes: H314. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H314 | |
| nonanoic acid | nonanoic acid | 112-05-0 | 203-931-2 | substance | Skin Irrit. 2; Eye Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H315; H319; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H319; H412 | |
| propyl 3,4,5-trihydroxybenzoate | propyl 3,4,5-trihydroxybenzoate | 121-79-9 | 204-498-2 | substance | Acute Tox. 4; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Oral: ATE = 1700 mg/kg bw | M = 1 | M = 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410. Date of Secretary of State decision: 2025-01-15. Date of entry into legal effect: 2025-02-15. Final compliance date: 2026-08-15 |
| octyl 3,4,5-trihydroxybenzoate | octyl 3,4,5-trihydroxybenzoate | 1034-01-1 | 213-853-0 | substance | Acute Tox. 4 *; Skin Sens. 1 | Hazard statement codes: H302; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H317 | |
| dodecyl 3,4,5-trihydroxybenzoate | dodecyl 3,4,5-trihydroxybenzoate | 1166-52-5 | 214-620-6 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| thiocarbonyl chloride | thiocarbonyl chloride | 463-71-8 | 207-341-6 | substance | Acute Tox. 3 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H331; H302; H319; H335; H315. Labelling pictogram and signal word: GHS06; Dgr. Labelling hazard statements: H331; H302; H319; H335; H315 | |
| 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate | 2-ethylhexyl[[[3,5-bis(1,1-dimethylethyl)-4-hydroxyphenyl]methyl]thio]acetate | 80387-97-9 | 279-452-8 | substance | Repr. 1B; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H360D ***; H317; H412. Labelling pictogram and signal word: GHS08; GHS07; Dgr. Labelling hazard statements: H360D ***; H317; H412 | |
| (chlorophenyl)(chlorotolyl)methane, mixed isomers | (chlorophenyl)(chlorotolyl)methane, mixed isomers | 400-140-6 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| methyl chloroacetate | methyl chloroacetate | 96-34-4 | 202-501-1 | substance | Flam. Liq. 3; Acute Tox. 3 *; Acute Tox. 3 *; STOT SE 3; Skin Irrit. 2; Eye Dam. 1 | Hazard statement codes: H226; H331; H301; H335; H315; H318. Labelling pictogram and signal word: GHS02; GHS06; GHS05; Dgr. Labelling hazard statements: H226; H331; H301; H335; H315; H318 | |
| isopropyl chloroacetate | isopropyl chloroacetate | 105-48-6 | 203-301-7 | substance | Flam. Liq. 3; Acute Tox. 3 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H226; H301; H319; H335; H315. Labelling pictogram and signal word: GHS02; GHS06; Dgr. Labelling hazard statements: H226; H301; H319; H335; H315 | |
| haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl) | haloxyfop-etotyl (ISO); 2-ethoxyethyl 2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate; haloxyfop-(2-ethoxyethyl) | 87237-48-7 | 402-560-5 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers | 4,8,12-trimethyltrideca-3,7,11-trienoic acid, mixed isomers | 91853-67-7 | 403-000-2 | substance | Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H410 | |
| reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate | reaction mass of O,O'-diisopropyl (pentathio)dithioformate and O,O'-diisopropyl (trithio)dithioformate and O,O'-diisopropyl (tetrathio)dithioformate | 403-030-6 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | ||
| methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) | methyl acrylamidoglycolate (containing ≥ 0,1 % acrylamide) | 77402-05-2 | 403-230-3 | substance | Carc. 1B; Muta. 1B; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H350; H340; H314; H317. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H350; H340; H314; H317 | |
| methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate | methyl 3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionate | 6386-39-6 | 403-270-1 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate | poly(oxypropylenecarbonyl-co-oxy(ethylethylene)carbonyl), containing 27 % hydroxyvalerate | 403-300-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| ethyl 3,3-bis(tert-pentylperoxy)butyrate | ethyl 3,3-bis(tert-pentylperoxy)butyrate | 67567-23-1 | 403-320-2 | substance | Org. Perox. D****; Flam. Liq. 3; Aquatic Chronic 2 | Hazard statement codes: H242; H226; H411. Labelling pictogram and signal word: GHS02; GHS09; Dgr. Labelling hazard statements: H242; H226; H411 | |
| N,N-hydrazinodiacetic acid | N,N-hydrazinodiacetic acid | 19247-05-3 | 403-510-5 | substance | Acute Tox. 3 *; STOT RE 2 *; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H301; H373 **; H317; H412. Labelling pictogram and signal word: GHS06; GHS08; Dgr. Labelling hazard statements: H301; H373 **; H317; H412 | |
| 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid | 3-(3-tert-butyl-4-hydroxyphenyl)propionic acid | 107551-67-7 | 403-920-4 | substance | Acute Tox. 4 *; Eye Irrit. 2 | Hazard statement codes: H302; H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319 | |
| glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine | glutamic acid, reaction products with N-(C12-14-alkyl)propylenediamine | 403-950-8 | substance | Acute Tox. 2 *; Acute Tox. 4 *; Skin Corr. 1B; Aquatic Acute 1 | Hazard statement codes: H330; H302; H314; H400. Labelling pictogram and signal word: GHS06; GHS05; GHS09; Dgr. Labelling hazard statements: H330; H302; H314; H400 | ||
| 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate | 2-ethoxyethyl 2-(4-(2,6-dihydro-2,6-dioxo-7-phenyl-1,5-dioxaindacen-3-yl)phenoxy)acetate | 403-960-2 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | ||
| dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid | dichlorprop-P (ISO); (+)-R-2-(2,4-dichlorophenoxy)propionic acid | 15165-67-0 | 403-980-1 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H315; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H315; H318; H317 | |
| bis(2-ethylhexyl) dithiodiacetate | bis(2-ethylhexyl) dithiodiacetate | 62268-47-7 | 404-510-8 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H411 | |
| 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid | 6-docosyloxy-1-hydroxy-4-(1-(4-hydroxy-3-methylphenanthren-1-yl)-3-oxo-2-oxaphenalen-1-yl)naphthalene-2-carboxylic acid | 404-550-6 | substance | Skin Sens. 1; Aquatic Chronic 4 | Hazard statement codes: H317; H413. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H413 | ||
| 6-(2,3-dimethylmaleimido)hexyl methacrylate | 6-(2,3-dimethylmaleimido)hexyl methacrylate | 63740-41-0 | 404-870-6 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate | transfluthrin (ISO); 2,3,5,6-tetrafluorobenzyl trans-2-(2,2-dichlorovinyl)-3,3-dimethylcyclopropanecarboxylate | 118712-89-3 | 405-060-5 | substance | Acute Tox. 4; Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 580 mg/kg bw | M=1000 | M=1000 | Hazard statement codes: H302; H351; H400; H410. Labelling pictogram and signal word: GHS07; GHS08; GHS09; Wng. Labelling hazard statements: H302; H351; H410. Supplementary hazard statements: EUH066. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| methyl 2-(3-nitrobenzylidene)acetoacetate | methyl 2-(3-nitrobenzylidene)acetoacetate | 39562-17-9 | 405-270-7 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| 3-azidosulfonylbenzoic acid | 3-azidosulfonylbenzoic acid | 15980-11-7 | 405-310-3 | substance | Self-react. C****; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H241; H373 **; H318; H317. Labelling pictogram and signal word: GHS02; GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H241; H373 **; H318; H317 | |
| reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane- 1,2-dicarboxylate | reaction mass of 2-acryloyloxyethyl hydrogen cyclohexane-1,2-dicarboxylate and 2-methacryloyloxyethyl hydrogen cyclohexane- 1,2-dicarboxylate | 405-360-6 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H315; H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H315; H318; H317; H412 | ||
| potassium 2-amino-2-methylpropionate octahydrate | potassium 2-amino-2-methylpropionate octahydrate | 120447-91-8 | 405-560-3 | substance | Acute Tox. 4 *; Skin Corr. 1A | Hazard statement codes: H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314 | |
| bis(2-methoxyethyl) phthalate | bis(2-methoxyethyl) phthalate | 117-82-8 | 204-212-6 | substance | Repr. 1B | Hazard statement codes: H360Df. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360Df | |
| diethylcarbamoyl chloride | diethylcarbamoyl chloride | 88-10-8 | 201-798-5 | substance | Carc. 2; Acute Tox. 4 *; Acute Tox. 4 *; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | Hazard statement codes: H351; H332; H302; H319; H335; H315. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H351; H332; H302; H319; H335; H315 | |
| 2-ethylhexanoic acid and its salts, with the exception of those specified elsewhere in this list | 2-ethylhexanoic acid and its salts, with the exception of those specified elsewhere in this list | substance | Repr. 1B | Hazard statement codes: H360D. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360D. Notes: The classification for the hazard class(es) in this entry is based only on the hazardous properties of the part of the substance which is common to all substances in the entry. The hazardous properties of any substance in the entry also depends on the properties of the part of the substance which is not common to all substances of the group; they must be evaluated to assess whether (a) more severe classification(s) (e.g. a higher category) or (b) a broader scope of the classification (additional differentiation, target organs and/or hazard statements) might apply for the hazard class(es) in the entry. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 | |||
| clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid | clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid | 1702-17-6 | 216-935-4 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate | pyridate (ISO); O-(6-chloro-3-phenylpyridazin-4-yl) S-octyl thiocarbonate | 55512-33-9 | 259-686-7 | substance | Acute Tox. 4; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | oral: ATE = 500 mg/kg bw | M = 1 | M = 10 | Hazard statement codes: H302; H315; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H315; H317; H410 |
| hexyl acrylate | hexyl acrylate | 2499-95-8 | 219-698-5 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H319; H335; H315; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H335; H315; H317; H411 | |
| flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid | flurenol (ISO); 9-hydroxy-9H-fluorene-9-carboxylic acid | 467-69-6 | 207-397-1 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| mecrilate; methyl 2-cyanoacrylate | mecrilate; methyl 2-cyanoacrylate | 137-05-3 | 205-275-2 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H319; H335; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H335; H315 |
| ethyl 2-cyanoacrylate | ethyl 2-cyanoacrylate | 7085-85-0 | 230-391-5 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H319; H335; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H335; H315 |
| benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole | benzyl 2-chloro-4-(trifluoromethyl)thiazole-5-carboxylate; flurazole | 72850-64-7 | 276-942-3 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate | tau-fluvalinate (ISO); cyano-(3-phenoxyphenyl)methyl N-[2-chloro-4-(trifluoromethyl)phenyl]-D-valinate | 102851-06-9 | substance | Acute Tox. 4 *; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H315; H410 | ||
| fenpropathrin (ISO); α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate | fenpropathrin (ISO); α-cyano-3-phenoxybenzyl 2,2,3,3-tetramethylcyclopropanecarboxylate | 39515-41-8 | 254-485-0 | substance | Acute Tox. 2 *; Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H330; H301; H312; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H301; H312; H410 | |
| cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1] 1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2] 1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3] tetrahydromethylphthalic anhydride; [4] 1,2,3,6-tetrahydromethylphthalic anhydride; [5] tetrahydro-4-methylphthalic anhydride; [6] 2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] | cis-1,2,3,6-tetrahydro-4-methylphthalic anhydride; [1] 1,2,3,6-tetrahydro-4-methylphthalic anhydride; [2] 1,2,3,6-tetrahydro-3-methylphthalic anhydride; [3] tetrahydromethylphthalic anhydride; [4] 1,2,3,6-tetrahydromethylphthalic anhydride; [5] tetrahydro-4-methylphthalic anhydride; [6] 2,3,5,6-tetrahydro-2-methylphthalic anhydride [7] | 1694-82-2 [1] 3425-89-6 [2] 5333-84-6 [3] 11070-44-3 [4] 26590-20-5 [5] 34090-76-1 [6] 42498-58-8 [7] | 216-906-6 [1] 222-323-8 [2] 226-247-6 [3] 234-290-7 [4] 247-830-1 [5] 251-823-9 [6] 255-853-3 [7] | substance | Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H318; H334; H317. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H318; H334; H317. Notes: C | |
| hexahydro-4-methylphthalic anhydride; [1] hexahydromethylphthalic anhydride; [2] hexahydro-1-methylphthalic anhydride; [3] hexahydro-3-methylphthalic anhydride [4] | hexahydro-4-methylphthalic anhydride; [1] hexahydromethylphthalic anhydride; [2] hexahydro-1-methylphthalic anhydride; [3] hexahydro-3-methylphthalic anhydride [4] | 19438-60-9 [1] 25550-51-0 [2] 48122-14-1 [3] 57110-29-9 [4] | 243-072-0 [1] 247-094-1 [2] 256-356-4 [3] 260-566-1 [4] | substance | Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 | Hazard statement codes: H318; H334; H317. Labelling pictogram and signal word: GHS08; GHS05; Dgr. Labelling hazard statements: H318; H334; H317. Notes: C | |
| tetrachlorophthalic anhydride | tetrachlorophthalic anhydride | 117-08-8 | 204-171-4 | substance | Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H334; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS09; Dgr. Labelling hazard statements: H318; H334; H317; H410 | |
| sodium 3,6-dichloro-o-anisate; [1] 3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2] 3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] | sodium 3,6-dichloro-o-anisate; [1] 3,6-dichloro-o-anisic acid, compound with 2,2'-iminodiethanol (1:1); [2] 3,6-dichloro-o-anisic acid, compound with 2-aminoethanol (1:1) [3] | 1982-69-0 [1] 25059-78-3 [2] 53404-28-7 [3] | 217-846-3 [1] 246-590-5 [2] 258-527-9 [3] | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| isooctyl acrylate | isooctyl acrylate | 29590-42-9 | 249-707-8 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Aquatic Acute 1; Aquatic Chronic 1 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H319; H335; H315; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H335; H315; H410 |
| tert-butyl acrylate | tert-butyl acrylate | 1663-39-4 | 216-768-7 | substance | Flam. Liq. 2; Acute Tox. 4 *; Acute Tox. 4 *; Acute Tox. 4 *; STOT SE 3 Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H225; H332; H312; H302; H335; H315; H317; H411. Labelling pictogram and signal word: GHS02; GHS07; GHS09; Dgr. Labelling hazard statements: H225; H332; H312; H302; H335; H315; H317; H411. Notes: D | |
| allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester | allyl methacrylate; 2-methyl-2-propenoic acid 2-propenyl ester | 96-05-9 | 202-473-0 | substance | Flam. Liq. 3; Acute Tox. 2; Acute Tox. 3; Acute Tox. 4; Aquatic Acute 1 | inhalation: ATE = 1,5 mg/L (vapours) | dermal: ATE = 300 mg/kg bw | oral: ATE = 400 mg/kg bw | Hazard statement codes: H226; H330; H311; H302; H400. Labelling pictogram and signal word: GGHS02; GHS09; GHS06; Dgr. Labelling hazard statements: H226; H330; H311; H302; H400. Date of Secretary of State decision: 2024-02-02. Date of entry into legal effect: 2024-03-02. Final compliance date: 2025-09-02 |
| dodecyl methacrylate | dodecyl methacrylate | 142-90-5 | 205-570-6 | substance | STOT SE 3 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H335. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H335 |
| naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate | naptalam-sodium (ISO); sodium N-naphth-1-ylphthalamate | 132-67-2 | 205-073-4 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate | (1-methyl-1,2-ethanediyl)bis[oxy(methyl-2,1-ethanediyl)] diacrylate | 42978-66-5 | 256-032-2 | substance | Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | STOT SE 3; | H335: C ≥ 10 % | Hazard statement codes: H319; H335; H315; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H335; H315; H317; H411 |
| 4H-3,1-benzoxazine-2,4(1H)-dione | 4H-3,1-benzoxazine-2,4(1H)-dione | 118-48-9 | 204-255-0 | substance | Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H319; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H317 | |
| 2-methoxypropyl acetate | 2-methoxypropyl acetate | 70657-70-4 | 274-724-2 | substance | Flam. Liq. 3; Repr. 1B; STOT SE 3 | Hazard statement codes: H226; H360D ***; H335. Labelling pictogram and signal word: GHS02; GHS08; GHS07; Dgr. Labelling hazard statements: H226; H360D ***; H335 | |
| lambda-cyhalothrin (ISO); reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) | lambda-cyhalothrin (ISO); reaction mass of (S)-α-cyano-3-phenoxybenzyl(Z)-(1R)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate and (R)-α-cyano-3-phenoxybenzyl (Z)-(1S)-cis-3-(2-chloro-3,3,3-trifluoropropenyl)-2,2-dimethylcyclopropanecarboxylate (1:1) | 91465-08-6 | 415-130-7 | substance | Acute Tox. 2 *; Acute Tox. 3 *; Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | M=10000 | Hazard statement codes: H330; H301; H312; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H301; H312; H410 |
| cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | cyfluthrin (ISO); α-cyano-4-fluoro-3-phenoxybenzyl-3-(2,2-dichlorovinyl)-2,2-dimethylcyclopropanecarboxylate | 68359-37-5 | 269-855-7 | substance | Acute Tox. 2; Acute Tox. 2; Lact.; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: | ATE = 0.14 mg/L (dusts/mists) | Oral: | ATE = 14 mg/kg bw | M = 1000000 | M = 1000000 | Hazard statement codes: H330; H300; H362; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H300; H362; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 |
| beta-cyfluthrin (ISO); reaction mass of rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl(1S,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate and rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl(1S,3R)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate | beta-cyfluthrin (ISO); reaction mass of rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl(1S,3S)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate and rel-(R)-cyano(4-fluoro-3-phenoxyphenyl)methyl(1S,3R)-3-(2,2-dichloroethenyl)-2,2-dimethylcyclopropane-1-carboxylate | 1820573-27-0 | substance | Acute Tox. 2; Acute Tox. 2; Lact.; Aquatic Acute 1; Aquatic Chronic 1 | Inhalation: | ATE = 0.081 mg/L (dusts/mists) | Oral: | ATE = 11 mg/kg bw | M = 1000000 | M = 1000000 | Hazard statement codes: H330; H300; H362; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H330; H300; H362; H410. Date of Secretary of State decision: 2023-09-23. Date of entry into legal effect: 2023-10-20. Final compliance date: 2025-04-20 | |
| fluroxypyr (ISO); 4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid | fluroxypyr (ISO); 4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyacetic acid | 69377-81-7 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| azoxystrobin (ISO); methyl (E)-2-{2-[6-(2- cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3- methoxyacrylate | azoxystrobin (ISO); methyl (E)-2-{2-[6-(2- cyanophenoxy)pyrimidin-4-yloxy]phenyl}-3- methoxyacrylate | 131860- 33-8 | substance | Acute Tox. 3; Aquatic Acute 1; Aquatic Chronic 1 | inhalation: ATE = 0.7 mg/L (dusts or mists) | M = 10 | M = 10 | Hazard statement codes: H331; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H410 | |
| isopropyl propionate | isopropyl propionate | 637-78-5 | 211-300-8 | substance | Flam. Liq. 2 | Hazard statement codes: H225. Labelling pictogram and signal word: GHS02; Dgr. Labelling hazard statements: H225 | |
| dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl) acetamido)-4-chlorobenzoate | dodecyl 3-(2-(3-benzyl-4-ethoxy-2,5-dioxoimidazolidin-1-yl)-3-(4-methoxybenzoyl) acetamido)-4-chlorobenzoate | 70950-45-7 | 403-990-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate | methyl 2R,3S-(-)-3-(4-methoxyphenyl)oxiranecarboxylate | 105560-93-8 | 404-130-2 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| ethyl 2-(3-nitrobenzylidene)acetoacetate | ethyl 2-(3-nitrobenzylidene)acetoacetate | 39562-16-8 | 404-490-0 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate | iso(C10-C14)alkyl (3,5-di-tert-butyl-4-hydroxyphenyl)methylthioacetate | 118832-72-7 | 404-800-4 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 7-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 86393-33-1 | 405-050-0 | substance | Acute Tox. 4 *; Aquatic Chronic 3 | Hazard statement codes: H302; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H412 | |
| potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate | potassium iron(III) 1,3-propanediamine-N,N,N',N'-tetraacetate hemihydrate | 405-680-6 | substance | Self-heat. 2 ****; Aquatic Chronic 2 | Hazard statement codes: H252; H411. Labelling pictogram and signal word: GHS02; GHS09; Wng. Labelling hazard statements: H252; H411 | ||
| 2-chloro-4-(methylsulfonyl)benzoic acid | 2-chloro-4-(methylsulfonyl)benzoic acid | 53250-83-2 | 406-520-8 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| ethyl-2-chloro-2,2-diphenylacetate | ethyl-2-chloro-2,2-diphenylacetate | 52460-86-3 | 406-580-5 | substance | Skin Irrit. 2; Aquatic Chronic 3 | Hazard statement codes: H315; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H315; H412 | |
| reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid | reaction mass of: hydroxyaluminium bis[2-hydroxy-3,5-di-tert-butylbenzoate]; 3,5-di-tert-butyl-salicylic acid | 130296-87-6 | 406-890-0 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | tert-butyl (5S,6R,7R)-3-bromomethyl-5,8-dioxo-7-(2-(2-phenylacetamido)-5-thia-1-azabicyclo[4.2.0] oct-2-ene-2-carboxylate | 33610-13-8 | 407-620-4 | substance | Resp. Sens. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H334; H317; H412. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334; H317; H412 | |
| 2-methylpropyl (R)-2-hydroxypropanoate | 2-methylpropyl (R)-2-hydroxypropanoate | 61597-96-4 | 407-770-0 | substance | Eye Irrit. 2 | Hazard statement codes: H319. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319 | |
| (R)-2-(4-hydroxyphenoxy)propanoic acid | (R)-2-(4-hydroxyphenoxy)propanoic acid | 94050-90-5 | 407-960-3 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane | 3,9-bis(2-(3-(3-tert-butyl-4-hydroxy-5-methylphenyl)propionyloxy-1,1-dimethylethyl)-2,4,8,10- tetraoxaspiro[5.5]undecane | 90498-90-1 | 410-730-5 | substance | Acute Tox. 4 * | Hazard statement codes: H312. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H312 | |
| 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane | 2-isopropyl-5-methylcyclohexyloxycarbonyloxy-2-hydroxypropane | 156324-82-2 | 417-420-9 | substance | Eye Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H319; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H319; H411 | |
| fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] | fluroxypyr-meptyl (ISO); methylheptyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate; [1] fluroxypyr-butometyl (ISO); 2-butoxy-1-methylethyl, O-(4-amino-3,5-dichloro-6-fluoro-2-pyridyloxy) acetate [2] | 81406-37-3 [1] 154486-27-8 [2] | 279-752-9 [1] - [2] | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate | ammonium 7-(2,6-dimethyl-8-(2,2-dimethylbutyryloxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)-3,5-dihydroxyheptanoate | 404-520-2 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate | 2-(N-benzyl-N-methylamino)ethyl 3-amino-2-butenoate | 54527-73-0 | 405-350-1 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| sodium benzoyloxybenzene-4-sulfonate | sodium benzoyloxybenzene-4-sulfonate | 66531-87-1 | 405-450-5 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex | bis[(1-methylimidazol)-(2-ethyl-hexanoate)], zinc complex | 405-635-0 | substance | Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H315; H318; H410 | ||
| reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate | reaction mass of: 2-(hexylthio)ethylamine hydrochloride; sodium propionate | 405-720-2 | substance | Acute Tox. 4 *; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H302; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H318; H317; H411 | ||
| reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate | reaction mass of isomers of: sodium phenethylnaphthalenesulfonate; sodium naphthylethylbenzenesulfonate | 405-760-0 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | ||
| reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate | reaction mass of n-octadecylaminodiethyl bis(hydrogen maleate); n-octadecylaminodiethyl hydrogen maleate hydrogenphthalate | 405-960-8 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| sodium 4-chloro-1-hydroxybutane-1-sulfonate | sodium 4-chloro-1-hydroxybutane-1-sulfonate | 54322-20-2 | 406-190-5 | substance | Acute Tox. 4 *; Eye Irrit. 2; Skin Sens. 1 | Hazard statement codes: H302; H319; H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302; H319; H317 | |
| reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates | reaction mass of branched and linear C7-C9 alkyl 3-[3-(2H-benzotriazol-2-yl)-5-(1,1-dimethylethyl)-4-hydroxyphenyl]propionates | 127519-17-9 | 407-000-3 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 2-acetoxymethyl-4-benzyloxybut-1-yl acetate | 2-acetoxymethyl-4-benzyloxybut-1-yl acetate | 131266-10-9 | 407-140-5 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| E-ethyl-4-oxo-4-phenylcrotonate | E-ethyl-4-oxo-4-phenylcrotonate | 15121-89-8 | 408-040-4 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H312; H302; H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H312; H302; H315; H318; H317; H410 | |
| reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-riphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) | reaction mass of: sodium 3,3'-(1,4-phenylenebis(carbonylimino-3,1-propanediylimino))bis(10-amino-6,13-dichloro-4,11-riphenodioxazinedisulfonate); lithium 3,3'-(1,4-phenylenebis-(carbonylimino-3,1-propanediyl-imino))bis(10-amino-6,13-dichloro)-4,11-triphenodioxazinedisulfonate (9:1) | 136213-76-8 | 410-040-4 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate | reaction mass of: 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonic acid; sodium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate; potassium 7-(((3-aminophenyl)sulfonyl)amino)-naphthalene-1,3-disulfonate | 410-065-0 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng | ||
| reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate | reaction mass of: sodium/potassium 7-[[[3-[[4-((2-hydroxy-naphthyl)azo)phenyl]azo]phenyl]sulfonyl]amino]-naphthalene-1,3-disulfonate | 141880-36-6 | 410-070-8 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| O'-methyl O-(1-methyl-2-methacryloyloxyethyl)-1,2,3,6-tetrahydrophthalate | O'-methyl O-(1-methyl-2-methacryloyloxyethyl)-1,2,3,6-tetrahydrophthalate | 410-140-8 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)- 4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II,,where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively | tetrasodium (c-(3-(1-(3-(e-6-dichloro-5-cyanopyrimidin-f-yl(methyl)amino)propyl)-1,6-dihydro-2-hydroxy-4-methyl-6-oxo-3-pyridylazo)- 4-sulfonatophenylsulfamoyl)phthalocyanine-a,b,d-trisulfonato(6-))nickelato II,,where a is 1 or 2 or 3 or 4,b is 8 or 9 or 10 or 11,c is 15 or 16 or 17 or 18, d is 22 or 23 or 24 or 25 and where e and f together are 2 and 4 or 4 and 2 respectively | 148732-74-5 | 410-160-7 | substance | Eye Irrit. 2; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H319; H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H317; H412 | |
| 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid | 3-(3-(4-(2,4-bis(1,1-dimethylpropyl)phenoxy)butylaminocarbonyl-4-hydroxy-1-naphthalenyl)thio)propanoic acid | 105488-33-3 | 410-370-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate | reaction mass (ratio not known) of: ammonium 1-C14-C18-alkyloxycarbonyl-2-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate; ammonium 2-C14-C18-alkyloxycarbonyl-1-(3-allyloxy-2-hydroxypropoxycarbonyl)ethane-1-sulfonate | 410-540-2 | substance | Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H317; H410 | ||
| dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate | dodecyl-ω-(C5/C6-cycloalkyl)alkyl carboxylate | 104051-92-5 | 410-630-1 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid | reaction mass of: [1-(methoxymethyl)-2-(C12-alkoxy)-ethoxy]acetic acid; [1-(methoxymethyl)-2-(C14-alkoxy)-ethoxy]acetic acid | 410-640-6 | substance | Skin Irrit. 2; Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H315; H318; H410 | ||
| reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate | reaction mass of: N-aminoethylpiperazonium mono-2,4,6-trimethylnonyldiphenyl ether di-sulfonate; N-aminoethylpiperazonium di-2,4,6-trimethylnonyldiphenyl ether di-sulfonate | 410-650-0 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H411 | ||
| sodium 2-benzoyloxy-1-hydroxyethane-sulfonate | sodium 2-benzoyloxy-1-hydroxyethane-sulfonate | 410-680-4 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate | reaction mass of: tetrasodium phosphonoethane-1,2-dicarboxylate; hexasodium phosphonobutane-1,2,3,4-tetracarboxylate | 410-800-5 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid | reaction mass of: pentaerythriol tetraesters with heptanoic acid and 2-ethylhexanoic acid | 410-830-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| (E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) | (E-E )-3,3'-(1,4-phenylenedimethylidene)bis(2-oxobornane-10-sulfonic acid) | 92761-26-7 | 410-960-6 | substance | Eye Dam. 1 | Hazard statement codes: H318. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318 | |
| 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate | 2-(trimethylammonium)ethoxycarboxybenzene-4-sulfonate | 411-010-3 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| methyl 3-(acetylthio)-2-methyl-propanoate | methyl 3-(acetylthio)-2-methyl-propanoate | 97101-46-7 | 411-040-7 | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410 | |
| trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-ulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25 | trisodium [2-(5-chloro-2,6-difluoropyrimidin-4-ylamino)-5-(b-sulfamoyl-c,d-sulfonatophthalocyanin-a-yl-K4,N29,N30,N31,N32-ulfonylamino)benzoato(5-)]cuprate(II) where a=1,2,3,4 b=8,9,10,11 c=15,16,17,18 d=22,23,24,25 | 411-430-7 | substance | Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317 | ||
| reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid | reaction mass of: dodecanoic acid; poly(1-7)lactate esters of dodecanoic acid | 411-860-5 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | ||
| reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid | reaction mass of: tetradecanoic acid; poly(1-7)lactate esters of tetradecanoic acid | 411-910-6 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H315; H318; H317; H411. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H315; H318; H317; H411 | ||
| 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 1-cyclopropyl-6,7-difluoro-1,4-dihydro-4-oxoquinoline-3-carboxylic acid | 93107-30-3 | 413-760-7 | substance | Repr. 2; Aquatic Chronic 3 | Hazard statement codes: H361f ***; H412. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H361f ***; H412 | |
| fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate | fluazifop-butyl (ISO); butyl (RS)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate | 69806-50-4 | 274-125-6 | substance | Repr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H360D ***; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360D ***; H410 | |
| fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate | fluazifop-P-butyl (ISO); butyl (R)-2-[4-(5-trifluoromethyl-2-pyridyloxy)phenoxy]propionate | 79241-46-6 | substance | Repr. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H361d ***; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H361d ***; H410 | ||
| chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate | chlozolinate (ISO); ethyl (RS)-3-(3,5-dichlorophenyl)-5-methyl-2,4-dioxo-oxazolidine-5-carboxylate | 84332-86-5 | 282-714-4 | substance | Carc. 2; Aquatic Chronic 2 | Hazard statement codes: H351; H411. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H411 | |
| vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione | vinclozolin (ISO); N-3,5-dichlorophenyl-5-methyl-5-vinyl-1,3-oxazolidine-2,4-dione | 50471-44-8 | 256-599-6 | substance | Carc. 2; Repr. 1B; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H351; H360FD; H317; H411. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Dgr. Labelling hazard statements: H351; H360FD; H317; H411 | |
| esters of 2,4-D | esters of 2,4-D | substance | Acute Tox. 4 *; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H317; H410. Notes: A | |||
| carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate | carfentrazone-ethyl (ISO); ethyl (RS)-2-chloro-3-[2-chloro-4-fluoro-5-[4-difluoromethyl-4,5-dihydro-3-methyl-5-oxo-1H-1,2,4-triazol-1-yl]phenyl]propionate | 128639-02-1 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | ||
| kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate | kresoxim-methyl (ISO); methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate | 143390-89-0 | substance | Carc. 2; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H351; H400; H410. Labelling pictogram and signal word: GHS08; GHS09; Wng. Labelling hazard statements: H351; H410 | ||
| benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate | benazolin-ethyl; ethyl 4-chloro-2-oxo-2H-benzothiazole-3-acetate | 25059-80-7 | 246-591-0 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| methoxyacetic acid | methoxyacetic acid | 625-45-6 | 210-894-6 | substance | Repr. 1B; Acute Tox. 4 *; Skin Corr. 1B | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H360FD; H302; H314. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H360FD; H302; H314 |
| neodecanoyl chloride | neodecanoyl chloride | 40292-82-8 | 254-875-0 | substance | Acute Tox. 2 *; Acute Tox. 4 *; Skin Corr. 1B | STOT SE 3; | H335: C ≥ 5 % | Hazard statement codes: H330; H302; H314. Labelling pictogram and signal word: GHS06; GHS06; Dgr. Labelling hazard statements: H330; H302; H314 |
| ethofumesate (ISO); (RS)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate | ethofumesate (ISO); (RS)-2-ethoxy-2,3-dihydro-3,3-dimethylbenzofuran-5-yl methanesulfonate | 26225- 79-6 | 247-525-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 |
| glyphosate (ISO); N-(phosphonomethyl)glycine | glyphosate (ISO); N-(phosphonomethyl)glycine | 1071-83-6 | 213-997-4 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | |
| glyphosate-trimesium; glyphosate-trimethylsulfonium | glyphosate-trimesium; glyphosate-trimethylsulfonium | 81591-81-3 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | ||
| bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP | bis(2-ethylhexyl) phthalate; di-(2-ethylhexyl) phthalate; DEHP | 117-81-7 | 204-211-0 | substance | Repr. 1B | Hazard statement codes: H360FD. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H360FD | |
| dibutyl phthalate; DBP | dibutyl phthalate; DBP | 84-74-2 | 201-557-4 | substance | Repr. 1B; Aquatic Acute 1 | Hazard statement codes: H360Df; H400. Labelling pictogram and signal word: GHS08; GHS09; Dgr. Labelling hazard statements: H360Df; H400 | |
| deltamethrin (ISO); (S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate | deltamethrin (ISO); (S)-α-cyano-3-phenoxybenzyl (1R, 3R)-3-(2,2-dibromovinyl)-2,2-dimethylcyclopropanecarboxylate | 52918-63-5 | 258-256-6 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | M=1000000 | Hazard statement codes: H331; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H301; H410 |
| bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate | bis[4-(ethenyloxy)butyl] 1,3-benzenedicarboxylate | 130066-57-8 | 413-930-0 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| (S)-methyl-2-chloropropionate | (S)-methyl-2-chloropropionate | 73246-45-4 | 412-470-8 | substance | Flam. Liq. 3; STOT RE 2 *; Eye Irrit. 2 | Hazard statement codes: H226; H373 **; H319. Labelling pictogram and signal word: GHS02; GHS08; Wng. Labelling hazard statements: H226; H373 **; H319 | |
| 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid | 4-(4,4-dimethyl-3-oxo-pyrazolidin-1-yl)-benzoic acid | 107144-30-9 | 413-120-7 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate | 2-(1-(2-hydroxy-3,5-di-tert-pentyl-phenyl)ethyl)-4,6-di-tert-pentylphenyl acrylate | 123968-25-2 | 413-850-6 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine | reaction mass of: N,N-di(hydrogenated alkyl C14-C18)phtalamic acid; dihydrogenated alkyl (C14-C18)amine | 413-800-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| (S)-2-chloropropionic acid | (S)-2-chloropropionic acid | 29617-66-1 | 411-150-5 | substance | Acute Tox. 4 *; Acute Tox. 4 *; Skin Corr. 1A | Hazard statement codes: H312; H302; H314. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H312; H302; H314 | |
| reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate | reaction mass of: isobutyl hydrogen 2-(α-2,4,6-trimethylnon-2-enyl)succinate; isobutyl hydrogen 2-(ß-2,4,6-trimetyhylnon-2-enyl)succinate | 141847-13-4 | 410-720-0 | substance | Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H411 | |
| 2-(2-iodoethyl)-1,3-propanediol diacetate | 2-(2-iodoethyl)-1,3-propanediol diacetate | 127047-77-2 | 411-780-0 | substance | Acute Tox. 4 *; Aquatic Chronic 2 | Hazard statement codes: H302; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H411 | |
| methyl 4-bromomethyl-3-methoxybenzoate | methyl 4-bromomethyl-3-methoxybenzoate | 70264-94-7 | 410-310-1 | substance | Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H315; H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H315; H318; H317; H410 | |
| reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate | reaction mass of: sodium 2-(C12-18-n-alkyl)amino-1,4-butandioate; sodium 2-octadecenyl-amino-1,4-butandioate | 411-250-9 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | ||
| (S)-2,3-dihydro-1H-indole-2-carboxylic acid | (S)-2,3-dihydro-1H-indole-2-carboxylic acid | 79815-20-6 | 410-860-2 | substance | Repr. 2; STOT RE 2 *; Skin Sens. 1 | Hazard statement codes: H361f ***; H373 **; H317. Labelling pictogram and signal word: GHS08; GHS07; Wng. Labelling hazard statements: H361f ***; H373 **; H317 | |
| cyclopentyl chloroformate | cyclopentyl chloroformate | 50715-28-1 | 411-460-0 | substance | Flam. Liq. 3; Acute Tox. 3 *; Acute Tox. 4 *; STOT RE 2 *; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H226; H331; H302; H373 **; H318; H317. Labelling pictogram and signal word: GHS02; GHS06; GHS08; GHS05; Dgr. Labelling hazard statements: H226; H331; H302; H373 **; H318; H317 | |
| reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate | reaction mass of: dodecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate; tetradecyl N-(2,2,6,6-tetramethylpiperidin-4-yl)-β-alaninate | 405-670-1 | substance | Acute Tox. 4 *; STOT RE 2 *; Skin Corr. 1B; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H373 **; H314; H400; H410. Labelling pictogram and signal word: GHS08; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H302; H373 **; H314; H410 | ||
| ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate | ethyl 1-ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxoquinoline-3-carboxylate | 100501-62-0 | 405-880-3 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate | methyl (R)-2-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenoxy)propionate | 72619-32-0 | 406-250-0 | substance | Acute Tox. 4 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H302; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H302; H410 | |
| 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate | 4-methyl-8-methylenetricyclo[3.3.1.13,7]dec-2-yl acetate | 122760-85-4 | 406-560-6 | substance | Skin Irrit. 2; Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H315; H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H317; H411 | |
| di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate | di-tert-(C12-14)-alkylammonium 2-benzothiazolylthiosuccinate | 125078-60-6 | 406-052-4 | substance | Flam. Liq. 3; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H226; H302; H315; H318; H411. Labelling pictogram and signal word: GHS02; GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H226; H302; H315; H318; H411 | |
| 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate | 2-methylpropyl 2-hydroxy-2-methylbut-3-enoate | 72531-53-4 | 406-235-9 | substance | Eye Irrit. 2; Skin Irrit. 2 | Hazard statement codes: H319; H315. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H319; H315 | |
| 2,3,4,5-tetrachlorobenzoylchloride | 2,3,4,5-tetrachlorobenzoylchloride | 42221-52-3 | 406-760-3 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H302; H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314; H317 | |
| 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate | 1,3-bis(4-benzoyl-3-hydroxyphenoxy)prop-2-yl acetate | 406-990-4 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | ||
| (9S)-9-amino-9-deoxyerythromycin | (9S)-9-amino-9-deoxyerythromycin | 26116-56-3 | 406-790-7 | substance | Eye Dam. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H400; H410. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H318; H410 | |
| 4-chlorobutyl veratrate | 4-chlorobutyl veratrate | 69788-75-6 | 410-950-1 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) | 4,7-methanooctahydro-1H-indene-diyldimethyl bis(2-carboxybenzoate) | 407-410-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate | reaction mass of: 3-(N-(3-dimethylaminopropyl)-(C4-8)perfluoroalkylsulfonamido)propionic acid; N-[dimethyl-3-(C4-8-perfluoroalkylsulfonamido)propylammonium propionate; 3-(N-(3-dimethyl-propylammonium)-(C4-8)perfluoroalkylsulfonamido)propionic acid propionate | 407-810-7 | substance | STOT RE 2 * | Hazard statement codes: H373 **. Labelling pictogram and signal word: GHS08; Wng. Labelling hazard statements: H373 ** | ||
| potassium 2-(2,4-dichlorophenoxy)-(R)-propionate | potassium 2-(2,4-dichlorophenoxy)-(R)-propionate | 113963-87-4 | 413-580-9 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H315; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H315; H318; H317 | |
| 3-icosyl-4-henicosylidene-2-oxetanone | 3-icosyl-4-henicosylidene-2-oxetanone | 83708-14-9 | 401-210-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| sodium (R)-2-(2,4-dichlorophenoxy)propionate | sodium (R)-2-(2,4-dichlorophenoxy)propionate | 119299-10-4 | 413-340-3 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H315; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H315; H318; H317 | |
| magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) | magnesium bis((R)-2-(2,4-dichlorophenoxy)propionate) | 413-360-2 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H315; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H315; H318; H317 | ||
| mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate | mono-(tetrapropylammonium) hydrogen 2,2'-dithiobisbenzoate | 411-270-8 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling hazard statements: H412 | ||
| bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane | bis(4-(1,2-bis(ethoxycarbonyl)ethylamino)-3-methylcyclohexyl)methane | 136210-32-7 | 412-060-9 | substance | Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H317; H412. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317; H412 | |
| methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate | methyl O-(4-amino-3,5-dichloro-6-fluoropyridin-2-yloxy)acetate | 69184-17-4 | 407-550-4 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| 4,4'-oxydiphthalic anhydride | 4,4'-oxydiphthalic anhydride | 1823-59-2 | 412-830-4 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | |
| reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate | reaction mass of: ethyl exo-tricyclo[5.2.1.02,6]decane-endo-2-carboxylate; ethyl endo-tricyclo[5.2.1.02,6]decane-exo-2-carboxylate | 80657-64-3 | 407-520-0 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | |
| ethyl 2-cyclohexylpropionate | ethyl 2-cyclohexylpropionate | 2511-00-4 | 412-280-5 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 | |
| p-tolyl 4-chlorobenzoate | p-tolyl 4-chlorobenzoate | 15024-10-9 | 411-530-0 | substance | Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H317; H400; H410. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H410 | |
| ethyl trans-2,2,6-trimethylcyclohexanecarboxylate | ethyl trans-2,2,6-trimethylcyclohexanecarboxylate | 412-540-8 | substance | Skin Irrit. 2; Aquatic Chronic 2 | Hazard statement codes: H315; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H315; H411 | ||
| reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran | reaction mass of: trans-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran; cis-4-acetoxy-4-methyl-2-propyl-tetrahydro-2H-pyran | 131766-73-9 | 412-450-9 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate | (1S,3S,5R,6R)-(4-nitrophenylmethyl)-1-dioxo-6-phenylacetamido-penam-3-carboxylate | 54275-93-3 | 412-670-5 | substance | Resp. Sens. 1 | Hazard statement codes: H334. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334 | |
| (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate | (1S,4R,6R,7R)-(4-nitrophenylmethyl)3-methylene-1-oxo-7-phenylacetamido-cepham-4-carboxylateido-penam-3-carboxylate | 76109-32-5 | 412-800-0 | substance | Resp. Sens. 1 | Hazard statement codes: H334. Labelling pictogram and signal word: GHS08; Dgr. Labelling hazard statements: H334 | |
| sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate | sodium 3-acetoacetylamino-4-methoxytolyl-6-sulfonate | 133167-77-8 | 411-680-7 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| methyl (R)-2-(4-hydroxyphenoxy)propionate | methyl (R)-2-(4-hydroxyphenoxy)propionate | 96562-58-2 | 411-950-4 | substance | Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H318; H412 | |
| reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl) hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate | reaction mass of: (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl) hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(2-(bis(2-hydroxyethyl)amino)ethoxycarbonylmethyl)tetradec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)hexadec-4-enoate; (3-methoxy)propylammonium/[tris-(2-hydroxyethyl)]ammonium 2-(3-methoxypropylcarbamoylmethyl)tetradec-4-enoate | 413-500-2 | substance | Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 2 | Hazard statement codes: H315; H318; H411. Labelling pictogram and signal word: GHS05; GHS09; Dgr. Labelling hazard statements: H315; H318; H411 | ||
| methyl-3-methoxyacrylate | methyl-3-methoxyacrylate | 5788-17-0 | 412-900-4 | substance | Skin Sens. 1 | Hazard statement codes: H317. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H317 | |
| 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione | 3-phenyl-7-[4-(tetrahydrofurfuryloxy)phenyl]-1,5-dioxa-s-indacen-2,6-dione | 134724-55-3 | 413-330-9 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling hazard statements: H413 | |
| 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride | 2-(2-amino-1,3-thiazol-4-yl)-(Z)-2-methoxyiminoacetyl chloride hydrochloride | 119154-86-8 | 410-620-7 | substance | Acute Tox. 4 *; Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H302; H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H314; H317 | |
| 3,5-dimethylbenzoyl chloride | 3,5-dimethylbenzoyl chloride | 6613-44-1 | 413-010-9 | substance | Skin Corr. 1B; Skin Sens. 1 | Hazard statement codes: H314; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H314; H317 | |
| potassium bis(N-carboxymethyl)-N-methylglycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate | potassium bis(N-carboxymethyl)-N-methylglycinato-(2-)N,O,O,N)-ferrate-(1-) monohydrate | 153352-59-1 | 411-640-9 | substance | Acute Tox. 4 * | Hazard statement codes: H302. Labelling pictogram and signal word: GHS07; Wng. Labelling hazard statements: H302 | |
| 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole | 1-(N,N-dimethylcarbamoyl)-3-tert-butyl-5-carbethoxymethylthio-1H-1,2,4-triazole | 110895-43-7 | 411-650-3 | substance | Acute Tox. 3 *; Acute Tox. 3 *; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H331; H301; H400; H410. Labelling pictogram and signal word: GHS06; GHS09; Dgr. Labelling hazard statements: H331; H301; H410 | |
| reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid | reaction mass of: trans-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid; cis-(2R)-5-acetoxy-1,3-oxathiolane-2-carboxylic acid | 147027-04-1 | 411-660-8 | substance | Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H302; H315; H318; H317. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H302; H315; H318; H317 | |
| 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol | 2-[[2-(acetyloxy)-3-(1,1-dimethyl-ethyl)-5-methylphenyl]methyl]-6-(1,1-dimethylethyl)-4-methylphenol | 41620-33-1 | 412-210-3 | substance | Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H400; H410. Labelling pictogram and signal word: GHS09; Wng. Labelling hazard statements: H410 | |
| 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate | 3-ethyl 5-methyl 4-(2-chlorophenyl)-1,4-dihydro-2-[2-(1,3-dihydro-1,3-dioxo-(2H)isoindol-2-yl)-ethoxymethyl]-6-methyl-3,5-pyridinedicarboxylate | 88150-62-3 | 413-410-3 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| ethoxylated bis phenol A di-(norbornene carboxylate) | ethoxylated bis phenol A di-(norbornene carboxylate) | 412-410-0 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| quizalofop-P-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-yloxy)phenyloxy]propionate | quizalofop-P-tefuryl (ISO); (+/–) tetrahydrofurfuryl (R)-2-[4-(6- chloroquinoxalin-2-yloxy)phenyloxy]propionate | 200509-41-7 | 414-200-4 | substance | Carc. 2; Repr. 2; Acute Tox. 4; STOT RE 2; Aquatic Acute 1; Aquatic Chronic 1 | M = 1 | M = 1 | Hazard statement codes: H351; H361fd; H302; H373; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H351; H361fd; H302; H373; H410 |
| 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride | 5-amino-2,4,6-triiodo-1,3-benzenedicarbonyldichloride | 37441-29-5 | 417-220-1 | substance | Skin Sens. 1; Aquatic Chronic 2 | Hazard statement codes: H317; H411. Labelling pictogram and signal word: GHS07; GHS09; Wng. Labelling hazard statements: H317; H411 | |
| flocoumafen (ISO); reaction mass of: cis-4- hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin | flocoumafen (ISO); reaction mass of: cis-4- hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin and trans-4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylbenzyloxy)phenyl)-1-naphthyl)coumarin | 90035-08-8 | 421-960-0 | substance | Repr. 1B; Acute Tox. 1; Acute Tox. 1; Acute Tox. 1; STOT RE 1; Aquatic Acute 1; Aquatic Chronic 1 | Repr. 1B; H360D: | C ≥ 0.003 % | STOT RE 1; H372 (blood): C ≥ 0.05 % | STOT RE 2; H373 (blood): 0.005 % ≤ C < 0.05 % | M = 10 | M = 10 | Hazard statement codes: H360D; H330; H310; H300; H372 (blood); H400; H410. Labelling pictogram and signal word: GHS08; GHS06; GHS09; Dgr. Labelling hazard statements: H360D; H330; H310; H300; H372 (blood); H410 |
| benzyl 2,4-dibromobutanoate | benzyl 2,4-dibromobutanoate | 23085-60-1 | 420-710-8 | substance | Repr. 2; Skin Irrit. 2; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H361f ***; H315; H317; H400; H410. Labelling pictogram and signal word: GHS08; GHS07; GHS09; Wng. Labelling hazard statements: H361f ***; H315; H317; H410 | |
| trans-4-cyclohexyl-L-proline monohydrochloride | trans-4-cyclohexyl-L-proline monohydrochloride | 90657-55-9 | 419-160-1 | substance | Repr. 2; Acute Tox. 4 *; Skin Irrit. 2; Eye Dam. 1; Skin Sens. 1 | Hazard statement codes: H361f ***; H302; H315; H318; H317. Labelling pictogram and signal word: GHS08; GHS05; GHS07; Dgr. Labelling hazard statements: H361f ***; H302; H315; H318; H317 | |
| ammonium (Z)-α-methoxyimino-2-furylacetate | ammonium (Z)-α-methoxyimino-2-furylacetate | 97148-39-5 | 405-990-1 | substance | Flam. Sol. 2 | Hazard statement codes: H228. Labelling pictogram and signal word: GHS02; Dgr. Labelling hazard statements: H228. Notes: T | |
| reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N,N-bis(2-hydroxyethyl)stearamide | reaction mass of: 2-[N-(2-hydroxyethyl)stearamido]ethyl stearate; sodium [bis[2-(stearoyloxy)ethyl]amino]methylsulfonate; sodium [bis(2-hydroxyethyl)amino]methylsulfonate; N,N-bis(2-hydroxyethyl)stearamide | 401-230-8 | substance | Aquatic Chronic 3 | Hazard statement codes: H412. Labelling pictogram and signal word: —. Labelling hazard statements: H412 | ||
| reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate | reaction mass of: ammonium-1,2-bis(hexyloxycarbonyl)ethanesulfonate; ammonium-1-hexyloxycarbonyl-2-octyloxycarbonylethanesulfonate; ammonium-2-hexyloxycarbonyl-1-octyloxycarbonylethanesulfonate | 407-320-3 | substance | Skin Irrit. 2; Eye Dam. 1; Aquatic Chronic 3 | Hazard statement codes: H315; H318; H412. Labelling pictogram and signal word: GHS05; Dgr. Labelling hazard statements: H315; H318; H412 | ||
| reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid | reaction mass of triesters of 2,2-bis(hydroxymethyl)butanol with C7-alkanoic acids and 2-ethylhexanoic acid | 413-710-4 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | ||
| 2-((4-amino-2-nitrophenyl)amino)benzoic acid | 2-((4-amino-2-nitrophenyl)amino)benzoic acid | 117907-43-4 | 411-260-3 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Chronic 3 | Hazard statement codes: H318; H317; H412. Labelling pictogram and signal word: GHS05; GHS07; Dgr. Labelling hazard statements: H318; H317; H412 | |
| reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate | reaction mass of: 2,2,6,6-tetramethylpiperidin-4-yl-hexadecanoate; 2,2,6,6-tetramethylpiperidin-4-yl-octadecanoate | 86403-32-9 | 415-430-8 | substance | Eye Dam. 1; Skin Sens. 1; Aquatic Acute 1; Aquatic Chronic 1 | Hazard statement codes: H318; H317; H400; H410. Labelling pictogram and signal word: GHS05; GHS07; GHS09; Dgr. Labelling hazard statements: H318; H317; H410 | |
| reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate | reaction mass of: esters of C14-C15 branched alcohols with 3,5-di-t-butyl-4-hydroxyphenyl propionic acid; C15 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate; C13 branched and linear alkyl 3,5-bis(1,1-dimethylethyl)-4-hydroxybenzenepropanoate | 171090-93-0 | 413-750-2 | substance | Aquatic Chronic 4 | Hazard statement codes: H413. Labelling pictogram and signal word: —. Labelling hazard statements: H413 | |
| Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate | Copolymer of vinyl-alcohol and vinyl acetate partially acetilized with 4-(2-(4-formylphenyl)ethenyl)-1-methylpyridinium methylsulfate | 125229-74-5 | 414-590-6 | substance | Aquatic Chronic 2 | Hazard statement codes: H411. Labelling pictogram and signal word: GHS09. Labelling hazard statements: H411 |
Official source
Entries are copied exactly as published. Not legal advice; always check the official text.